Nordson (NDSN) 10-Q 4 Sep 20 2020 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Jul. 31, 2020	Aug. 25, 2020
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jul. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Trading Symbol	NDSN
Entity Registrant Name	NORDSON CORPORATION
Entity Central Index Key	0000072331
Current Fiscal Year End Date	--10-31
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding		58,034,535
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity File Number	0-7977
Entity Tax Identification Number	34-0590250
Entity Address, Address Line One	28601 Clemens Road
Entity Address, City or Town	Westlake
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	44145
City Area Code	440
Local Phone Number	892-1580
Entity Interactive Data Current	Yes
Title of 12(b) Security	Common Shares, without par value
Security Exchange Name	NASDAQ
Entity Incorporation, State or Country Code	OH
Document Quarterly Report	true
Document Transition Report	false

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income (UNAUDITED) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2020	Jul. 31, 2019	Jul. 31, 2020	Jul. 31, 2019
Income Statement [Abstract]
Sales	$ 538,181	$ 559,746	$ 1,562,575	$ 1,608,775
Operating costs and expenses:
Cost of sales	257,373	257,123	728,975	735,647
Selling and administrative expenses	168,753	172,347	521,423	529,675
Total operating costs and expenses	426,126	429,470	1,250,398	1,265,322
Operating profit	112,055	130,276	312,177	343,453
Other income (expense):
Interest expense	(7,314)	(11,500)	(25,348)	(36,238)
Interest and investment income	434	511	1,301	1,153
Other - net	(9,668)	210	(12,943)	(4,546)
Total other income (expense)	(16,548)	(10,779)	(36,990)	(39,631)
Income before income taxes	95,507	119,497	275,187	303,822
Income taxes	8,526	25,569	44,123	69,404
Net income	$ 86,981	$ 93,928	$ 231,064	$ 234,418
Average common shares	57,693	57,395	57,679	57,463
Incremental common shares attributable to equity compensation	734	722	725	720
Average common shares and common share equivalents	58,427	58,117	58,404	58,183
Basic earnings per share	$ 1.51	$ 1.64	$ 4.01	$ 4.08
Diluted earnings per share	$ 1.49	$ 1.62	$ 3.96	$ 4.03

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2020	Jul. 31, 2019	Jul. 31, 2020	Jul. 31, 2019
Statement Of Income And Comprehensive Income [Abstract]
Net income	$ 86,981	$ 93,928	$ 231,064	$ 234,418
Components of other comprehensive income (loss):
Foreign currency translation adjustments	28,943	(7,172)	10,509	227
Amortization of prior service cost and net actuarial losses, net of tax	2,621	2,378	9,748	5,328
Total other comprehensive income (loss)	31,564	(4,794)	20,257	5,555
Total comprehensive income	$ 118,545	$ 89,134	$ 251,321	$ 239,973

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (UNAUDITED) - USD ($) $ in Thousands	Jul. 31, 2020	Oct. 31, 2019
Current assets:
Cash and cash equivalents	$ 221,783	$ 151,164
Receivables - net	498,283	530,765
Inventories - net	310,557	283,399
Prepaid expenses and other current assets	50,075	45,867
Total current assets	1,080,698	1,011,195
Property, plant and equipment - net	414,982	398,895
Operating right of use lease assets	132,062
Goodwill	1,701,914	1,614,739
Intangible assets - net	435,817	445,575
Deferred income taxes	11,674	11,261
Other assets	42,811	34,782
Total assets	3,819,958	3,516,447
Current liabilities:
Accounts payable	71,355	85,139
Income taxes payable	635	15,601
Accrued liabilities	161,044	161,655
Customer advanced payments	45,713	41,131
Current maturities of long-term debt	43,598	168,738
Operating lease liability - current	18,636
Finance lease liability - current	6,237	5,362
Total current liabilities	347,218	477,626
Long-term debt	1,221,082	1,075,404
Operating lease liability - noncurrent	117,609
Finance lease liability - noncurrent	10,969	9,513
Deferred income taxes	85,363	83,564
Pension obligations	132,769	158,506
Postretirement obligations	87,448	86,368
Other long-term liabilities	47,588	44,421
Shareholders' equity:
Common shares	12,253	12,253
Capital in excess of stated value	526,923	483,116
Retained earnings	2,912,848	2,747,650
Accumulated other comprehensive loss	(211,624)	(231,881)
Common shares in treasury, at cost	(1,470,488)	(1,430,093)
Total shareholders' equity	1,769,912	1,581,045
Total liabilities and shareholders' equity	$ 3,819,958	$ 3,516,447

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Shareholders' Equity (UNAUDITED) - USD ($) $ in Thousands	Total	Common Shares [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Common Shares in Treasury, At Cost [Member]
Balance at Oct. 31, 2018	$ 1,450,741	$ 12,253	$ 446,555	$ 2,488,375	$ (179,314)	$ (1,317,128)
Shares issued under company stock and employee benefit plans	3,607		1,016			2,591
Stock-based compensation	4,359		4,359
Purchase of treasury shares, value	(107,667)					(107,667)
Dividends declared	(20,210)			(20,210)
Net income	48,567			48,567
Impact of adoption of ASU | ASU 2014-09 [Member]	4,329			4,329
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	16,463				16,463
Defined benefit pension and post-retirement plans adjustment	1,352				1,352
Balance at Jan. 31, 2019	1,401,541	12,253	451,930	2,521,061	(161,499)	(1,422,204)
Balance at Oct. 31, 2018	1,450,741	12,253	446,555	2,488,375	(179,314)	(1,317,128)
Net income	234,418
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	227
Balance at Jul. 31, 2019	1,546,888	12,253	470,951	2,666,797	(173,759)	(1,429,354)
Balance at Jan. 31, 2019	1,401,541	12,253	451,930	2,521,061	(161,499)	(1,422,204)
Shares issued under company stock and employee benefit plans	10,847		8,116			2,731
Stock-based compensation	4,869		4,869
Purchase of treasury shares, value	(10,422)					(10,422)
Dividends declared	(20,029)			(20,029)
Net income	91,923			91,923
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	(9,064)				(9,064)
Defined benefit pension and post-retirement plans adjustment	1,598				1,598
Balance at Apr. 30, 2019	1,471,263	12,253	464,915	2,592,955	(168,965)	(1,429,895)
Shares issued under company stock and employee benefit plans	2,821		2,245			576
Stock-based compensation	3,791		3,791
Purchase of treasury shares, value	(35)					(35)
Dividends declared	(20,086)			(20,086)
Net income	93,928			93,928
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	(7,172)				(7,172)
Defined benefit pension and post-retirement plans adjustment	2,378				2,378
Balance at Jul. 31, 2019	1,546,888	12,253	470,951	2,666,797	(173,759)	(1,429,354)
Balance at Oct. 31, 2019	1,581,045	12,253	483,116	2,747,650	(231,881)	(1,430,093)
Shares issued under company stock and employee benefit plans	16,379		12,330			4,049
Stock-based compensation	6,105		6,105
Purchase of treasury shares, value	(4,311)					(4,311)
Dividends declared	(21,915)			(21,915)
Net income	52,004			52,004
Impact of adoption of ASU | ASU 2016-02 [Member]	(1,055)			(1,055)
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	2,793				2,793
Defined benefit pension and post-retirement plans adjustment	3,229				3,229
Balance at Jan. 31, 2020	1,634,274	12,253	501,551	2,776,684	(225,859)	(1,430,355)
Balance at Oct. 31, 2019	1,581,045	12,253	483,116	2,747,650	(231,881)	(1,430,093)
Net income	231,064
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	10,509
Balance at Jul. 31, 2020	1,769,912	12,253	526,923	2,912,848	(211,624)	(1,470,488)
Balance at Jan. 31, 2020	1,634,274	12,253	501,551	2,776,684	(225,859)	(1,430,355)
Shares issued under company stock and employee benefit plans	2,168		2,362			(194)
Stock-based compensation	(72)		(72)
Purchase of treasury shares, value	(37,619)					(37,619)
Dividends declared	(21,963)			(21,963)
Net income	92,079			92,079
Impact of adoption of ASU | ASU 2016-02 [Member]	956			956
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	(21,227)				(21,227)
Defined benefit pension and post-retirement plans adjustment	3,898				3,898
Balance at Apr. 30, 2020	1,652,494	12,253	503,841	2,847,756	(243,188)	(1,468,168)
Shares issued under company stock and employee benefit plans	27,757		20,110			7,647
Stock-based compensation	2,972		2,972
Purchase of treasury shares, value	(9,967)					(9,967)
Dividends declared	(21,859)			(21,859)
Net income	86,981			86,981
Impact of adoption of ASU | ASU 2016-02 [Member]	(30)			(30)
Other Comprehensive Income (Loss):
Foreign currency translation adjustments	28,943				28,943
Defined benefit pension and post-retirement plans adjustment	2,621				2,621
Balance at Jul. 31, 2020	$ 1,769,912	$ 12,253	$ 526,923	$ 2,912,848	$ (211,624)	$ (1,470,488)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Shareholders' Equity (UNAUDITED) (Parenthetical) - $ / shares shares in Thousands	3 Months Ended
	Jul. 31, 2020	Apr. 30, 2020	Jan. 31, 2020	Jul. 31, 2019	Apr. 30, 2019	Jan. 31, 2019
Statement Of Stockholders Equity [Abstract]
Purchase of treasury shares, shares	53,735	300,894	26,223	261	78,957	901,545
Dividends declared per share	$ 0.38	$ 0.38	$ 0.38	$ 0.35	$ 0.35	$ 0.35

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows (UNAUDITED) - USD ($) $ in Thousands	9 Months Ended
	Jul. 31, 2020	Jul. 31, 2019
Cash flows from operating activities:
Net income	$ 231,064	$ 234,418
Depreciation and amortization	84,164	83,331
Non-cash stock compensation	9,005	13,019
Deferred income taxes	(6,402)	(1,828)
Other non-cash expense	5,874	2,455
Loss on sale of property, plant and equipment	274	1,053
Changes in operating assets and liabilities	(14,021)	(96,017)
Net cash provided by operating activities	309,958	236,431
Cash flows from investing activities:
Additions to property, plant and equipment	(36,096)	(46,002)
Proceeds from sale of property, plant and equipment	164	1,037
Equity investments	(2,000)	(844)
Acquisition of businesses, net of cash acquired	(125,260)	(12,110)
Net cash used in investing activities	(163,192)	(57,919)
Cash flows from financing activities:
Proceeds from long-term debt	165,734	184,892
Repayment of long-term debt	(163,994)	(148,883)
Repayment of finance lease obligations	(5,814)	(4,442)
Issuance of common shares	46,304	17,275
Purchase of treasury shares	(51,897)	(118,124)
Dividends paid	(65,737)	(60,325)
Net cash used in financing activities	(75,404)	(129,607)
Effect of exchange rate changes on cash	(743)	3,262
Increase in cash and cash equivalents	70,619	52,167
Cash and cash equivalents:
Beginning of year	151,164	95,678
End of period	$ 221,783	$ 147,845

Significant Accounting Policies

Significant Accounting Policies	9 Months Ended
	Jul. 31, 2020
Accounting Policies [Abstract]
Significant Accounting Policies	1. Significant accounting policies Basis of presentation realignment of our operating segments. Refer to Note 11 for details on our operating segments Basis of consolidation Use of estimates Revenue recognition . A contract exists when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. Revenue is recognized when performance obligations under the terms of the contract with a customer are satisfied. Generally, our revenue results from short-term, fixed-price contracts and primarily is recognized as of a point in time when the product is shipped or at a later point when the control of the product transfers to the customer. Revenue for undelivered items is deferred and included within Accrued liabilities in our Consolidated Balance Sheets. Revenues deferred as of July 31, 2020 and 2019 were not material. However, for certain contracts related to the sale of customer-specific products within our Advanced Technology Solutions segment, revenue for these contracts is recognized over time as we satisfy performance obligations because of the continuous transfer of control to the customer. The continuous transfer of control to the customer occurs as we enhance assets that are customer controlled and we are contractually entitled to payment for work performed to date plus a reasonable margin. As control transfers over time for these products or services, revenue is recognized based on progress toward completion of the performance obligations. The selection method to measure progress towards completion requires judgment and is based on the nature of the products or services to be provided. We have elected to use the input method – costs incurred for these contracts because it best depicts the transfer of products or services to the customer based on incurring costs on the contract. Under this method, revenues are recorded proportionally as costs are incurred. Contract assets recognized are recorded in Prepaid expenses and other current assets and contract liabilities are recorded in Accrued liabilities in our Consolidated Balance Sheets and were not material at July 31, 2020 and October 31, 2019. Revenue recognized over time is not material to our overall Consolidated Financial Statements. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Sales, value add, and other taxes we collect concurrently with revenue-producing activities are excluded from revenue. As a practical expedient, we may exclude the assessment of whether goods or services are performance obligations, if they are immaterial in the context of the contract, and combine these with other performance obligations. While payment terms and conditions vary by contract type, we have determined that our contracts generally do not include a significant financing component. We have elected to apply the practical expedient to treat all shipping and handling costs as fulfillment costs as a significant portion of these costs are incurred prior to transfer of control to the customer. We have also elected to apply the practical expedient to expense sales commissions as they are incurred as the amortization period resulting from capitalizing the costs is one year or less. These costs are recorded within Selling and administrative expenses in our Consolidated Statements of Income. We offer assurance type warranties on our products as well as separately sold warranty contracts. Revenue related to warranty contracts that are sold separately is recognized over the life of the warranty term. Certain arrangements may include installation, installation supervision, training, and spare parts, which tend to be completed in a short period of time, at an insignificant cost, and utilizing skills not unique to us, and, therefore, are typically regarded as inconsequential or not material. We disclose disaggregated revenues by operating segment and geography in accordance with the revenue standard and on the same basis used internally by the chief operating decision maker for evaluating performance of operating segments and for allocating resources. Refer to Note 11 for details on our operating segments. Earnings per share ptions were excluded from the calculation of diluted earnings per share for the three months ended July 31, 2019.

Recently Issued Accounting Stan

Recently Issued Accounting Standards	9 Months Ended
	Jul. 31, 2020
Accounting Changes And Error Corrections [Abstract]
Recently Issued Accounting Standards	2 . Recently issued accounting standards New accounting guidance adopted: On November 1, 2019, we adopted Accounting Standards Update (ASU) 2016-02, Accounting Standards Codification (ASC) 842, “Leases.” This standard requires a lessee to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases with a lease term of more than 12 months. We elected to use the transition option, which allows entities to initially apply the new standard at the adoption date and recognize a cumulative effect adjustment to the opening balance of retained earnings in the period of adoption without restating prior periods. New accounting guidance issued and not yet adopted: In June 2016, the Financial Accounting Standards Board (FASB) issued ASU 2016-13, “Financial Instruments – Credit Losses (Topic 326),” which changes the impairment model for most financial instruments. Current guidance requires the recognition of credit losses based on an incurred loss impairment methodology that reflects losses once the losses are probable. We will be required to use a current expected credit loss model that will immediately recognize an estimate of credit losses that are expected to occur over the life of the financial instruments that are in the scope of this update, including trade receivables. The standard does not prescribe a specific method to make an estimate so the application will require judgment and should consider historical information, current information, and reasonable and supportable forecasts, and includes estimates of prepayment. This guidance will become effective for us on November 1, 2020. We are advancing in the implementation process as we are gathering and evaluating historical data to determine our policy and are reviewing our business processes and controls to support the recognition and disclosure under the new standard, and are currently assessing the impact this standard will have on our Consolidated Financial Statements. In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820),” a new standard which removes, modifies, and adds certain disclosure requirements on fair value measurements. The guidance removes disclosure requirements pertaining to the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements. For investments in certain entities that calculate net asset value, an entity is required to disclose the timing of liquidation of an investee’s assets and the date when restrictions from redemption might lapse only if the investee has communicated the timing to the entity or announced the timing publicly. In addition, the amendment clarifies that the measurement uncertainty disclosure is to communicate information about the uncertainty in measurement as of the reporting date. The guidance adds disclosure requirements for changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period as well as the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. It will be effective for us beginning November 1, 2020. Early adoption is permitted. We currently do not expect this standard will have a material impact on our Consolidated Financial Statements. In August 2018, the FASB issued ASU 2018-15, “Intangibles – Goodwill and Other Internal-Use Software (Subtopic 350-40),” a new standard which makes a number of changes meant to help entities evaluate the accounting for fees paid by a customer in a cloud computing arrangement (hosting arrangement), by providing guidance in determining when the arrangement includes a software license. In August 2018, the FASB issued ASU 2018-14, “Compensation – Retirement Benefits – Defined Benefit Plans – General (Subtopic 715-20),” a new standard which addresses defined benefit plans. The amendments modify the following disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans: the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit cost over the next fiscal year, amount and timing of plan assets expected to be returned to the employer, related party disclosure about the amount of future annual benefits covered by insurance and annuity contracts and significant transactions between the employer or related parties and the plan, and the effects of a one-percentage point change in assumed health care cost trend rates on the (a) aggregate of the service and interest cost components of net periodic benefit costs and (b) benefit obligations for postretirement health care benefits. A disclosure requirement was added for the explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period. Additionally, the standard clarifies disclosure requirements surrounding the projected benefit obligation (PBO) and fair value of plan assets for plans with PBOs in excess of plan assets and the accumulated benefit obligation (ABO) and fair value of plan assets for plans with ABOs in excess of plan assets. It will be effective for us beginning November 1, 2021. Early adoption is permitted. We are currently assessing the impact this standard will have on our Consolidated Financial Statements. In December 2019, the FASB issued ASU 2019-12, “Income Taxes (ASC 740) – Simplifying the Accounting for Income Taxes,” which simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740. The amendments also improve consistent application of and simplify U.S. GAAP for other areas of ASC 740 by clarifying and amending existing guidance. It will be effective for us beginning November 1, 2021. Early adoption is permitted, including adoption in any interim period for which financial statements have not yet been issued. Depending on the amendment, adoption may be applied on the retrospective, modified retrospective or prospective basis. We are currently assessing the impact of this standard on our Consolidated Financial Statements.

Acquisitions

Acquisitions	9 Months Ended
	Jul. 31, 2020
Business Combinations [Abstract]
Acquisitions	3 . Acquisitions Business acquisitions have been accounted for using the acquisition method, with the acquired assets and liabilities recorded at estimated fair value on the dates of acquisition. The cost in excess of the net assets of the business acquired is included in goodwill. Operating results since the respective dates of acquisitions are included in the Consolidated Statements of Income. 2020 acquisition On June 1, 2020, we acquired 100% of the outstanding shares of Fluortek, Inc., a precision plastic extrusion manufacturer that provides custom dimensioned tubing to the medical device industry. We acquired Fluortek for an aggregate purchase price of $ , net of cash and other closing adjustments of approximately $ , utilizing cash on hand. This acquisition is being reported in our Advanced Technology Solutions segment and the results for Fluortek are not material to the company’s consolidated financial statements. As of July 31, 2020, the purchase price allocations remain preliminary as we complete our assessments of intangible assets and income taxes. 2019 acquisition On July 1, 2019, we purchased certain assets of Optical Control GmbH & Co. KG (“Optical”), a Nuremberg, Germany designer and developer of high speed, fully automatic counting systems utilizing x-ray technology. This transaction was not material to our Consolidated Financial Statements. We recorded the acquisition of Optical based on the fair value of the assets acquired and the liabilities assumed. Goodwill associated with this acquisition is tax deductible. This acquisition is being reported in our Advanced Technology Solutions segment.

Inventories

Inventories	9 Months Ended
	Jul. 31, 2020
Inventory Disclosure [Abstract]
Inventories	4 . At July 31, 2020 and October 31, 2019, inventories consisted of the following: July 31, 2020 October 31, 2019 Finished goods $ 196,611 $ 183,973 Raw materials and component parts 107,145 102,044 Work-in-process 54,123 42,904 357,879 328,921 Obsolescence and other reserves (41,570 ) (39,377 ) LIFO reserve (5,752 ) (6,145 ) $ 310,557 $ 283,399

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	9 Months Ended
	Jul. 31, 2020
Goodwill And Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	5 . Goodwill and other intangible assets Changes in the carrying amount of goodwill for the nine months ended July 31, 2020 by operating segment are as follows: Industrial Precision Solutions Advanced Technology Solutions Total Balance at October 31, 2019 $ 411,461 $ 1,203,278 $ 1,614,739 Acquisitions — 76,047 76,047 Currency effect 6,088 5,040 11,128 Balance at July 31, 2020 $ 417,549 $ 1,284,365 $ 1,701,914 As part of our change in operating segments as described in Note 11, we considered whether the reporting units used for purposes of assessing impairment of goodwill should be changed and concluded that no changes were necessary. Information regarding our intangible assets subject to amortization is as follows: July 31, 2020 Carrying Accumulated Amortization Net Customer relationships $ 503,804 $ 203,589 $ 300,215 Patent/technology costs 163,550 81,590 81,960 Trade name 98,691 46,553 52,138 Non-compete agreements 12,472 10,972 1,500 Other 1,401 1,397 4 Total $ 779,918 $ 344,101 $ 435,817 October 31, 2019 Carrying Accumulated Amortization Net Book Value Customer relationships $ 480,007 $ 173,996 $ 306,011 Patent/technology costs 154,735 71,663 83,072 Trade name 96,655 41,303 55,352 Non-compete agreements 11,540 10,406 1,134 Other 1,400 1,394 6 Total $ 744,337 $ 298,762 $ 445,575 Amortization expense for the three months ended July 31, 2020 and 2019 was $16,577 and $13,903, respectively. Amortization expense for the nine months ended July 31, 2020 and 2019 was $47,410 and $41,665, respectively. Refer to Note 3 for an explanation of the change in goodwill and intangible assets due to the Fluortek acquisition.

Pension and Other Postretiremen

Pension and Other Postretirement Plans	9 Months Ended
	Jul. 31, 2020
Compensation And Retirement Disclosure [Abstract]
Pension and Other Postretirement Plans	6 . Pension and other postretirement plans The components of net periodic pension cost for the three and nine months ended July 31, 2020 and 2019 were: U.S. International Three Months Ended 2020 2019 2020 2019 Service cost $ 5,146 $ 3,740 $ 519 $ 484 Interest cost 3,970 4,736 256 416 Expected return on plan assets (6,165 ) (5,908 ) (313 ) (397 ) Amortization of prior service credit (21 ) (16 ) (72 ) (76 ) Amortization of net actuarial loss 3,510 1,938 739 424 Settlement loss 2,508 — — — Total benefit cost $ 8,948 $ 4,490 $ 1,129 $ 851 U.S. International Nine Months Ended 2020 2019 2020 2019 Service cost $ 15,439 $ 10,895 $ 1,550 $ 1,454 Interest cost 11,913 13,726 769 1,262 Expected return on plan assets (18,499 ) (17,506 ) (948 ) (1,204 ) Amortization of prior service credit (63 ) (46 ) (214 ) (228 ) Amortization of net actuarial loss 10,529 5,026 2,201 1,280 Settlement loss 2,508 — — — Total benefit cost $ 21,827 $ 12,095 $ 3,358 $ 2,564 During the third quarter of 2020, we recognized a settlement loss of $2,508 as a result of a lump sum distribution from our supplemental executive retirement plan. The components of other postretirement benefit cost for the three and nine months ended July 31, 2020 and 2019 were: U.S. International Three Months Ended 2020 2019 2020 2019 Service cost $ 187 $ 70 $ 4 $ 3 Interest cost 657 698 3 3 Amortization of prior service credit (5 ) (6 ) — — Amortization of net actuarial (gain) loss 380 162 (9 ) (5 ) Total benefit cost $ 1,219 $ 924 $ (2 ) $ 1 U.S. International Nine Months Ended 2020 2019 2020 2019 Service cost $ 520 $ 401 $ 11 $ 13 Interest cost 1,830 2,195 10 15 Amortization of prior service credit (13 ) (20 ) — — Amortization of net actuarial (gain) loss 1,057 467 (27 ) (22 ) Total benefit cost $ 3,394 $ 3,043 $ (6 ) $ 6 The components of net periodic pension cost other than service cost are included in Other – net in our Consolidated Statements of Income.

Income Taxes

Income Taxes	9 Months Ended
	Jul. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	7 . Income taxes We record our interim provision for income taxes based on our estimated annual effective tax rate, as well as certain items discrete to the current period. The effective tax rate for the three and nine months ended July 31, 2020 was 8.9% and 16.0%, respectively. The effective tax rate for the three and nine months ended July 31, 2019 was 21.4% and 22.8%, respectively. The effective tax rate for the three and nine months ended July 31, 2020 was lower than the comparable prior year periods primarily due to excess tax benefits associated with share-based payment transactions. Due to our share-based payment transactions our income tax provision included a discrete tax benefit of $11,373 and $14,048 for the three and nine months ended July 31, 2020, respectively. Our income tax provision included a similar discrete tax benefit of $210 and $3,227 for the three and nine months ended July 31, 2019, respectively. During the nine months ended July 31, 2019, a discrete tax expense of $4,866 was recorded to update the provisional amounts recognized in 2018 due to changes in interpretations and assumptions and the finalization of estimates related to the U.S. Tax Cuts and Jobs Act. During the three months ended July 31, 2020 and July 31, 2019, we recorded a favorable adjustment to unrecognized tax benefits of $443 and $858, respectively. In addition, during the three months ended July 31, 2020 there was an increase of $5,664 in unrecognized tax benefits and, if recognized, the gross unrecognized tax benefits would be offset against assets currently recorded in the Consolidated Balance Sheet.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	9 Months Ended
	Jul. 31, 2020
Equity [Abstract]
Accumulated Other Comprehensive Loss	8 . Accumulated other comprehensive loss The components of accumulated other comprehensive loss, including adjustments for items that are reclassified from accumulated other comprehensive loss to net income, are shown below. Cumulative Pension and Accumulated translation postretirement benefit other comprehensive adjustments plan adjustments loss Balance at October 31, 2019 $ (53,332 ) $ (178,549 ) $ (231,881 ) Amortization of prior service costs and net actuarial losses, net of tax of $(3,026) — 9,748 9,748 Foreign currency translation adjustments 10,509 — 10,509 Balance at July 31, 2020 $ (42,823 ) $ (168,801 ) $ (211,624 )

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Jul. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock-Based Compensation	9 . Stock-based compensation During the 2018 Annual Meeting of Shareholders, our shareholders approved the Amended and Restated 2012 Stock Incentive and Award Plan (the “2012 Plan”). The 2012 Plan provides for the granting of stock options, stock appreciation rights, restricted shares, restricted share units, performance shares, cash awards and other stock or performance-based incentives. A maximum of 4,525 common shares were originally available for grant under the 2012 Plan. Stock Options Nonqualified or incentive stock options may be granted to our employees and directors. Generally, options granted to employees may be exercised beginning one year from the date of grant at a rate not exceeding 25 percent per year and expire 10 years from the date of grant. Vesting accelerates upon a qualified termination in connection with a change in control. In the event of termination of employment due to early retirement or normal retirement at age 65, options granted within 12 months prior to termination are forfeited, and vesting continues post retirement for all other unvested options granted. In the event of disability or death, all unvested stock options granted within 12 months prior to termination (or at any time prior to December 28, 2017) fully vest. Termination for any other reason results in forfeiture of unvested options and vested options in certain circumstances. The amortized cost of options is accelerated if the retirement eligibility date occurs before the normal vesting date. Option exercises are satisfied through the issuance of treasury shares on a first-in, first-out basis. We recognized compensation expense related to stock options of $2,385 and $2,525 in the three months ended July 31, 2020 and 2019, respectively. Corresponding amounts for the nine months ended July 31, 2020 and 2019 were $7,648 and $7,583, respectively. The following table summarizes activity related to stock options for the nine months ended July 31, 2020: Number of Options Weighted- Average Exercise Share Aggregate Intrinsic Value Weighted Average Remaining Term Outstanding at October 31, 2019 1,787 $ 97.74 Granted 391 166.38 Exercised (587 ) 78.87 Forfeited or expired (39 ) 144.70 Outstanding at July 31, 2020 1,552 $ 121.00 $ 112,752 7.2 years Expected to vest 853 $ 141.34 $ 44,597 8.4 years Exercisable at July 31, 2020 689 $ 95.33 $ 67,769 5.7 years As of July 31, 2020, there was $13,963 of total unrecognized compensation cost related to unvested stock options. That cost is expected to be amortized over a weighted average period of approximately 1.7 years. The fair value of each option grant was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions: Nine months ended July 31, 2020 July 31, 2019 Expected volatility 24.5%-30.5% 24.1%-24.5% Expected dividend yield 0.87%-1.16% 1.04% Risk-free interest rate 0.44%-1.69% 2.84%-2.95% Expected life of the option (in years) 5.3-6.3 5.3-6.2 The weighted-average expected volatility used to value the 2020 and 2019 options was 25.4% and 24.3%, respectively. Historical information was the primary basis for the selection of the expected volatility, expected dividend yield and the expected lives of the options. The risk-free interest rate was selected based upon yields of U.S. Treasury issues with a term equal to the expected life of the option being valued. The weighted average grant date fair value of stock options granted during the nine months ended July 31, 2020 and 2019 was $38.57 and $31.74, respectively. The total intrinsic value of options exercised during the three months ended July 31, 2020 and 2019 was $39,811 and $2,449, respectively. The total intrinsic value of options exercised during the nine months ended July 31, 2020 and 2019 was $58,758 and $21,770, respectively. Cash received from the exercise of stock options for the nine months ended July 31, 2020 and 2019 was $46,304 and $17,275, respectively. Restricted Shares and Restricted Share Units We may grant restricted shares and/or restricted share units to our employees and directors. These shares or units may not be transferred for a designated period of time (generally one to three years) defined at the date of grant. For employee recipients, in the event of termination of employment due to early retirement with the consent of the Company, restricted shares granted within 12 months prior to termination are forfeited, and other restricted shares vest on a pro-rata basis. In the event of termination of employment due to normal retirement at age 65, restricted shares granted within 12 months prior to termination are forfeited, and, for other restricted shares, the restriction period will lapse and the shares will vest and be transferable. For restricted shares granted within 12 months prior to termination (or at any time prior to December 28, 2017), the restrictions lapse in the event of a recipient’s disability or death. Termination for any other reason prior to the lapse of any restrictions results in forfeiture of the shares. For non-employee directors, all restrictions lapse in the event of disability or death of the non-employee director. Termination of service as a director for any other reason within one year of date of grant results in a pro-rata vesting of shares or units. As shares or units are issued, deferred stock-based compensation equivalent to the fair value on the date of grant is expensed over the vesting period. The following table summarizes activity related to restricted shares during the nine months ended July 31, 2020: Number of Shares Weighted-Average Grant Date Fair Value Restricted shares at October 31, 2019 66 $ 126.83 Granted 25 169.62 Forfeited (6 ) 131.06 Vested (26 ) 120.23 Restricted shares at July 31, 2020 59 $ 147.17 As of July 31, 2020, there was $5,053 of unrecognized compensation cost related to restricted shares. The cost is expected to be amortized over a weighted average period of 2.0 years. The amount charged to expense related to restricted shares during the three months ended July 31, 2020 and 2019 was $734 and $898, respectively. These amounts included common share dividends for the three months ended July 31, 2020 and 2019 of $21 and $22, respectively. For the nine months ended July 31, 2020 and 2019, the amounts charged to expense related to restricted shares were $2,995 and $2,762, respectively. These amounts included common share dividends for the nine months ended July 31, 2020 and 2019 of $64 and $58, respectively. The following table summarizes activity related to restricted share units during the nine months ended July 31, 2020: Number of Units Weighted-Average Grant Date Fair Value Restricted share units at October 31, 2019 — $ — Granted 7 160.68 Restricted share units at July 31, 2020 7 $ 160.68 As of July 31, 2020, there was $295 of remaining expense to be recognized related to outstanding restricted share units, which is expected to be recognized over a weighted average period of 0.3 years. The amount charged to expense related to restricted share units during each of the three months ended July 31, 2020 and 2019 was $299 and $263, respectively. For the nine months ended July 31, 2020 and 2019, the corresponding amounts were $883 and $789, respectively. Performance Share Incentive Awards Executive officers and selected other key employees are eligible to receive common share-based incentive awards. Payouts, in the form of unrestricted common shares, vary based on the degree to which corporate financial performance exceeds predetermined threshold, target and maximum performance goals over three-year performance periods. No payout will occur unless threshold performance is achieved. The amount of compensation expense is based upon current performance projections for each three-year Deferred Compensation Our executive officers and other highly compensated employees may elect to defer up to 100% of their base pay and cash incentive and for executive officers, up to 90% of their share-based performance incentive payout each year. Additional share units are credited for quarterly dividends paid on our common shares. Expense related to dividends paid under this plan for the three months ended July 31, 2020 and 2019 was $83 and $74, respectively. For the nine months ended July 31, 2020 and 2019, the corresponding amounts were $247 and $219, respectively. Deferred Directors’ Compensation Non-employee directors may defer all or part of their cash and equity-based compensation until retirement. Cash compensation may be deferred as cash or as share equivalent units. Deferred cash amounts are recorded as liabilities, and share equivalent units are recorded as equity. Additional share equivalent units are earned when common share dividends are declared. The following table summarizes activity related to director deferred compensation share equivalent units during the nine months ended July 31, 2020: Number of Shares Weighted-Average Grant Date Fair Value Outstanding at October 31, 2019 114 $ 55.52 Dividend equivalents 1 164.44 Outstanding at July 31, 2020 115 $ 56.27 The amount charged to expense related to director deferred compensation for the three months ended July 31, 2020 and 2019 was $44 and $ 38

Warranties

Warranties	9 Months Ended
	Jul. 31, 2020
Guarantees [Abstract]
Warranties	10 . Warranties We offer warranties to our customers depending on the specific product and terms of the customer purchase agreement. A typical warranty program requires that we repair or replace defective products within a specified time period (generally one year) from the date of delivery or first use. We record an estimate for future warranty-related costs based on actual historical return rates. Based on analysis of return rates and other factors, the adequacy of our warranty provisions are adjusted as necessary. The liability for warranty costs is included in Accrued liabilities in the Consolidated Balance Sheet. Following is a reconciliation of the product warranty liability for the nine months ended July 31, 2020 and 2019: July 31, 2020 July 31, 2019 Beginning balance at October 31 $ 11,006 $ 12,195 Accruals for warranties 8,219 7,628 Warranty payments (8,180 ) (7,837 ) Currency effect 221 (78 ) Ending balance $ 11,266 $ 11,908

Operating Segments

Operating Segments	9 Months Ended
	Jul. 31, 2020
Segment Reporting [Abstract]
Operating Segments	11 . Operating segments We conduct business across two primary operating segments: Industrial Precision Solutions (IPS) and Advanced Technology Solutions (ATS). The composition of segments and measure of segment profitability is consistent with that used by our chief operating decision maker. The primary measure used by the chief operating decision maker for purposes of making decisions about allocating resources to the segments and assessing performance is operating profit, which equals sales less cost of sales and certain operating expenses. Items below the operating profit line of the Consolidated Statements of Income (interest and investment income, interest expense and other income/expense) are excluded from the measure of segment profitability reviewed by our chief operating decision maker and are not presented by operating segment. Effective in the second quarter of 2020, we made changes to realign our management team and our operating segments. This realignment will enable us to better serve global customers and markets, to more efficiently leverage technology synergies, to operate divisions of significant size in a consistent and focused way and to position ourselves for our next chapter of profitable growth. The revised operating segments better reflect how we manage the Company, allocate resources, and assess performance of the businesses. We realigned our former three operating segments into two: Industrial Precision Solutions and Advanced Technology Solutions. Existing product lines were unchanged as part of this new structure. Industrial Precision Solutions: This segment combines our former Adhesive Dispensing Systems (ADS) and Industrial Coating Systems (ICS) businesses. IPS enhances the technology synergies between ADS and ICS to deliver proprietary dispensing and processing technology to diverse end markets. Product lines reduce material consumption, increase line efficiency and enhance product brand and appearance. Components are used for dispensing adhesives, coatings, paint, finishes, sealants and other materials. This segment primarily serves the industrial, consumer durables and non-durables markets. Advanced Technology Solutions: This segment integrates our proprietary product technologies found in progressive stages of a customer’s production processes, such as surface treatment, precisely controlled dispensing of material and post-dispense test and inspection to ensure quality. Related single-use plastic molded syringes, cartridges, tips, fluid connection components, tubing, balloons and catheters are used to dispense or control fluids in production processes or within customers’ end products. This segment predominantly serves customers in the electronics, medical and related high-tech industrial markets. The financial information presented herein reflects the impact of the preceding changes and prior periods have been revised to reflect these changes. The following table presents information about our segments: Industrial Precision Solutions Advanced Technology Solutions Corporate Total Three months ended July 31, 2020 Net external sales $ 288,965 $ 249,216 $ — $ 538,181 Operating profit (loss) 74,744 49,952 (12,641 ) 112,055 July 31, 2019 Net external sales $ 306,648 $ 253,098 $ — $ 559,746 Operating profit (loss) 88,811 53,562 (12,097 ) 130,276 Nine months ended July 31, 2020 Net external sales $ 835,038 $ 727,537 $ — $ 1,562,575 Operating profit (loss) 207,603 140,928 (36,354 ) 312,177 July 31, 2019 Net external sales $ 871,925 $ 736,850 $ — $ 1,608,775 Operating profit (loss) 229,702 150,882 (37,131 ) 343,453 A reconciliation of total segment operating income to total consolidated income before income taxes is as follows: Three Months Ended Nine Months Ended July 31, 2020 July 31, 2019 July 31, 2020 July 31, 2019 Total profit for reportable segments $ 112,055 $ 130,276 $ 312,177 $ 343,453 Interest expense (7,314 ) (11,500 ) (25,348 ) (36,238 ) Interest and investment income 434 511 1,301 1,153 Other-net (9,668 ) 210 (12,943 ) (4,546 ) Income before income taxes $ 95,507 $ 119,497 $ 275,187 $ 303,822 We have significant sales in the following geographic regions: Three Months Ended Nine Months Ended July 31, 2020 July 31, 2019 July 31, 2020 July 31, 2019 United States $ 183,508 $ 190,460 $ 560,941 $ 551,510 Americas 38,265 47,040 106,021 123,159 Europe 132,107 143,449 394,554 425,650 Japan 31,226 30,488 90,353 89,566 Asia Pacific 153,075 148,309 410,706 418,890 Total net external sales $ 538,181 $ 559,746 $ 1,562,575 $ 1,608,775

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Jul. 31, 2020
Fair Value Disclosures [Abstract]
Fair Value Measurements	12 . Fair value measurements The inputs to the valuation techniques used to measure fair value are classified into the following categories: Level 1: Quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs that are not corroborated by market data. The following tables present the classification of our assets and liabilities measured at fair value on a recurring basis: July 31, 2020 Total Level 1 Level 2 Level 3 Assets: Foreign currency forward contracts (a) $ 22,241 $ — $ 22,241 $ — Total assets at fair value $ 22,241 $ — $ 22,241 $ — Liabilities: Deferred compensation plans (b) $ 12,030 $ — $ 12,030 $ — Foreign currency forward contracts (a) 6,484 — 6,484 — Total liabilities at fair value $ 18,514 $ — $ 18,514 $ — October 31, 2019 Total Level 1 Level 2 Level 3 Assets: Foreign currency forward contracts (a) $ 5,042 $ — $ 5,042 $ — Total assets at fair value $ 5,042 $ — $ 5,042 $ — Liabilities: Deferred compensation plans (b) $ 11,850 $ — $ 11,850 $ — Foreign currency forward contracts (a) 2,381 — 2,381 — Total liabilities at fair value $ 14,231 $ — $ 14,231 $ — (a) We enter into foreign currency forward contracts to reduce the risk of foreign currency exposures resulting from receivables, payables, intercompany receivables, intercompany payables and loans denominated in foreign currencies. Foreign exchange contracts are valued using market exchange rates. These foreign exchange contracts are not designated as hedges. (b) Executive officers and other highly compensated employees may defer up to 100 percent of their salary and annual cash incentive compensation and for executive officers, up to 90 percent of their long-term incentive compensation, into various non-qualified deferred compensation plans. Deferrals can be allocated to various market performance measurement funds. Changes in the value of compensation deferred under these plans are recognized each period based on the fair value of the underlying measurement funds. The carrying amounts and fair values of financial instruments, other than cash and cash equivalents, receivables, and accounts payable, are shown in the table below. The carrying values of cash and cash equivalents, receivables and accounts payable approximate fair value due to the short-term nature of these instruments. July 31, 2020 Carrying Amount Fair Value Long-term debt (including current portion), excluding unamortized debt issuance costs 1,264,680 1,330,739 We used the following methods and assumptions in estimating the fair value of financial instruments: • Long-term debt is valued by discounting future cash flows at currently available rates for borrowing arrangements with similar terms and conditions, which are considered to be Level 2 inputs under the fair value hierarchy.

Derivative Financial Instrument

Derivative Financial Instruments	9 Months Ended
	Jul. 31, 2020
Investments All Other Investments [Abstract]
Derivative Financial Instruments	13 . Derivative financial instruments We operate internationally and enter into intercompany transactions denominated in foreign currencies. Consequently, we are subject to market risk arising from exchange rate movements between the dates foreign currency transactions occur and the dates they are settled. We regularly use foreign currency forward contracts to reduce our risks related to most of these transactions. These contracts usually have maturities of 90 days or less and generally require us to exchange foreign currencies for U.S. dollars at maturity, at rates stated in the contracts. These contracts are not designated as hedging instruments under U.S. GAAP. Accordingly, the changes in the fair value of the foreign currency forward contracts are recognized in each accounting period in “Other – net” on the Consolidated Statements of Income together with the transaction gain or loss from the related balance sheet position. For the three months ended July 31, 2020, we recognized net gains of $17,255 on foreign currency forward contracts and net losses of $20,809 from the change in fair value of balance sheet positions. For the three months ended July 31, 2019, we recognized net gains of $975 on foreign currency forward contracts and net gains of $407 from the change in fair value of balance sheet positions. For the nine months ended July 31, 2020, we recognized net gains of $13,096 on foreign currency forward contracts and losses of $13,658 from the change in fair value of balance sheet positions. For the nine months ended July 31, 2019, we recognized gains of $769 on foreign currency forward contracts and gains of $267 from the change in fair value of balance sheet positions. The following table summarizes, by currency, the foreign currency forward contracts outstanding at July 31, 2020 and 2019: Notional Amounts July 31, 2020 contract amounts: Sell Buy Euro $ 108,856 $ 207,198 British pound 18,861 60,397 Japanese yen 15,815 32,009 Australian dollar 174 7,682 Hong Kong dollar 56,279 74,714 Singapore dollar 1,357 15,982 Others 4,412 59,921 Total $ 205,754 $ 457,903 Notional Amounts July 31, 2019 contract amounts: Sell Buy Euro $ 219,910 $ 90,043 British pound 20,542 45,955 Japanese yen 32,560 48,670 Australian dollar 350 7,683 Hong Kong dollar 1,209 136,818 Singapore dollar 782 15,449 Others 3,460 63,388 Total $ 278,813 $ 408,006 We are exposed to credit-related losses in the event of nonperformance by counterparties to financial instruments. These financial instruments include cash deposits and foreign currency forward contracts. We periodically monitor the credit ratings of these counterparties in order to minimize our exposure. Our customers represent a wide variety of industries and geographic regions. For the nine months ended July 31, 2020 and 2019, there were no significant concentrations of credit risk.

Leases

Leases	9 Months Ended
	Jul. 31, 2020
Leases [Abstract]
Leases	14 . Leases We review new contracts to determine if the contracts include a lease. To the extent a lease agreement includes an extension option that is reasonably certain to be exercised, we have recognized those amounts as part of the right-of-use assets and lease liabilities. We combine lease and non-lease components, such as common area maintenance, in the calculation of the lease assets and related liabilities. As most lease agreements do not provide an implicit rate, we use an incremental borrowing rate (IBR) based on information available at the lease commencement date in determining the present value of lease payments and to help classify the lease as operating or financing. We calculate the IBR based on a bond yield curve which considers secured borrowing rates based on our credit rating and current economic environment, as well as other publicly available data. We lease certain manufacturing facilities, warehouse space, machinery and equipment, and vehicles. We often have options to renew lease terms for buildings and other assets. We evaluate renewal and termination options at the lease commencement date to determine if we are reasonably certain to exercise the option on the basis of economic factors. Leases with an initial term of 12 months or less (short-term l eases) are not recorded on the Consolidated Balance S heet. Lease expense for operating leases is recognized on a straight-line basis over the lease term, with variable lease payments recognized in the period those payment s occur. Variable payments for leases primarily relate to future rates or amounts, miles, or other quantifiable usage factors which are not determinable at the time the lease agreement commences. Finance lease assets are recorded in Property, plant, and equipment – net on the Consolidated Balance Sheet. As of July 31 , 2020, we have no material leases that have yet to commence. Additional lease information is summarized below for the three and nine months ended July 31, 2020: Three months ended Nine months ended July 31, 2020 July 31, 2020 Finance Leases Operating Leases Finance Leases Operating Leases Amortization of right of use assets $ 1,779 $ — $ 5,293 $ — Interest 93 — 266 — Lease cost (1) 1,872 5,406 5,559 16,073 Short-term and variable lease cost (1) 200 617 1,023 1,917 Total lease cost $ 2,072 $ 6,023 $ 6,582 $ 18,000 (1) Lease costs are recorded in both Cost of sales and Selling and administrative expenses on the Consolidated Statements of Income. Supplemental cash flow information is summarized below for the nine months ended July 31, 2020: Finance Leases Operating Leases Cash outflows for leases $ 5,814 $ 15,935 Weighted average remaining lease term (years) 4.72 years 10.48 years Weighted average discount rate 2.51 % 1.69 % The following table reconciles the undiscounted cash flows for five years and thereafter to the operating and finance lease liabilities recognized on the statement of financial position as of July 31, 2020. The reconciliation excludes short-term leases that are not recognized on the Consolidated Balance Sheet. Year: Finance Leases Operating Leases 2020 $ 6,479 $ 20,709 2021 4,445 19,056 2022 2,735 16,106 2023 1,130 14,163 2024 669 12,160 Later years 3,210 68,085 Total minimum lease payments $ 18,668 $ 150,279 Amounts representing interest 1,462 14,034 Present value of minimum lease payments $ 17,206 $ 136,245

Long-Term Debt

Long-Term Debt	9 Months Ended
	Jul. 31, 2020
Debt Disclosure [Abstract]
Long-Term Debt	15 . Long-term debt A summary of long-term debt is as follows: July 31, 2020 October 31, 2019 Senior notes, due 2020-2025 $ 109,900 $ 140,800 Senior notes, due 2020-2027 85,714 92,857 Senior notes, due 2023-2030 350,000 350,000 Term loan, due 2022-2024 405,000 505,000 Euro loan, due 2023 312,022 128,219 Private shelf facility, due 2020 5,556 30,556 Development loans, due 2020-2026 — 951 1,268,192 1,248,383 Less current maturities 43,598 168,738 Less unamortized debt issuance costs 3,512 4,241 Long-term maturities $ 1,221,082 $ 1,075,404 In March 2020 we amended, restated and extended the term of our existing term loan facility with Bank of America Merrill Lynch International Limited. The interest rate is variable based on the EURIBOR rate. The Term Loan Agreement provides for the following term loans in two tranches: € 115,000 due in March 2023 and an additional € 150,000 that was drawn down in March 2020 and is due in March 2023. The weighted average interest rate at July 31, 2020 was 0.71%. At July 31, 2020, the balance outstanding was € 265,000 ($312,022). We were in compliance with all covenants at July 31, 2020. In April 2019, we amended, restated and extended the term of our existing $605,000 term loan facility with a group of banks. The interest rate is variable based upon the LIBOR rate. At July 31, 2020, $405,000 was outstanding under this facility. The Term Loan Agreement provides for the following term loans in two tranches: $200,000 due in September 2022, and $205,000 due in March 2024. The weighted average interest rate for borrowings under this agreement was 0.82% at July 31, 2020. We were in compliance with all covenants at July 31, 2020. In April 2019, we entered into a $850,000 unsecured, multicurrency credit facility with a group of banks, which amended, restated and extended our existing syndicated revolving credit agreement that was scheduled to expire in February 2020. This facility has a five-year In June 2018, we entered into a Note Purchase Agreement with a group of insurance companies under which we sold $350,000 of Senior Notes to the insurance companies and their affiliates. The notes start to mature between June 2023 and June 2030 and bear interest at fixed rates between 3.71% and 4.17%. We were in compliance with all covenants at July 31, 2020. In July 2015, we entered into a Note Purchase Agreement with a group of insurance companies under which we sold $100,000 of unsecured Senior Notes. At July 31, 2020 and October 31, 2019, $85,714 and $92,857, respectively, was outstanding under this agreement. Existing notes mature between July 2021 and July 2027 and bear interest at fixed rates between 2.89% and 3.19%. We were in compliance with all covenants at July 31, 2020. In 2012, we entered into a Note Purchase Agreement with a group of insurance companies under which we sold $200,000 of unsecured Senior Notes. At July 31, 2020 and October 31, 2019, $109,900 and $140,800, respectively, was outstanding under this agreement. Existing notes mature between July 2021 and July 2025 and bear interest at fixed rates between 2.62% and 3.13%. We were in compliance with all covenants at July 31, 2020. We entered into a $150,000 three-year

Contingencies

Contingencies	9 Months Ended
	Jul. 31, 2020
Commitments And Contingencies Disclosure [Abstract]
Contingencies	16 . Contingencies We are involved in pending or potential litigation regarding environmental, product liability, patent, contract, employee and other matters arising from the normal course of business. Including the litigation and environmental matters discussed below, after consultation with legal counsel, we do not believe that losses in excess of the amounts we have accrued would have a material adverse effect on our financial condition, quarterly or annual operating results or cash flows. Class Action Litigation On February 22, 2019, a former employee, Mr. Ortiz, filed a purported class action lawsuit in the San Diego County Superior Court, California, against Nordson Asymtek, Inc. and Nordson Corporation, alleging various violations of the California Labor Code. Plaintiff seeks, among other things, an unspecified amount for unpaid wages, actual, consequential and incidental losses, penalties, and attorneys’ fees and costs . Following mediation in June 2020, the parties agreed to settle the lawsuit, subject to the execution of a written settlement agreement and court approval. If the settlement agreement is approved, the class action lawsuit will be resolved. Management believes, based on currently available information, that the ultimate outcome of the proceeding described above will not have a material adverse effect on the Company’s financial condition or results of operations. Environmental We have voluntarily agreed with the City of New Richmond, Wisconsin and other Potentially Responsible Parties to share costs associated with the remediation of the City of New Richmond municipal landfill (the “Site”) and the construction of a potable water delivery system serving the impacted area down gradient of the Site. At July 31, 2020 and October 31, 2019, our accrual for the ongoing operation, maintenance and monitoring obligation at the Site was $360 and $401, respectively. The liability for environmental remediation represents management’s best estimate of the probable and reasonably estimable undiscounted costs related to known remediation obligations. The accuracy of our estimate of environmental liability is affected by several uncertainties such as additional requirements that may be identified in connection with remedial activities, the complexity and evolution of environmental laws and regulations, and the identification of presently unknown remediation requirements. Consequently, our liability could be greater than our current estimate. However, we do not expect that the costs associated with remediation will have a material adverse effect on our financial condition or results of operations.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	9 Months Ended
	Jul. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of presentation realignment of our operating segments. Refer to Note 11 for details on our operating segments
Basis of Consolidation	Basis of consolidation
Use of Estimates	Use of estimates
Revenue Recognition	Revenue recognition . A contract exists when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. Revenue is recognized when performance obligations under the terms of the contract with a customer are satisfied. Generally, our revenue results from short-term, fixed-price contracts and primarily is recognized as of a point in time when the product is shipped or at a later point when the control of the product transfers to the customer. Revenue for undelivered items is deferred and included within Accrued liabilities in our Consolidated Balance Sheets. Revenues deferred as of July 31, 2020 and 2019 were not material. However, for certain contracts related to the sale of customer-specific products within our Advanced Technology Solutions segment, revenue for these contracts is recognized over time as we satisfy performance obligations because of the continuous transfer of control to the customer. The continuous transfer of control to the customer occurs as we enhance assets that are customer controlled and we are contractually entitled to payment for work performed to date plus a reasonable margin. As control transfers over time for these products or services, revenue is recognized based on progress toward completion of the performance obligations. The selection method to measure progress towards completion requires judgment and is based on the nature of the products or services to be provided. We have elected to use the input method – costs incurred for these contracts because it best depicts the transfer of products or services to the customer based on incurring costs on the contract. Under this method, revenues are recorded proportionally as costs are incurred. Contract assets recognized are recorded in Prepaid expenses and other current assets and contract liabilities are recorded in Accrued liabilities in our Consolidated Balance Sheets and were not material at July 31, 2020 and October 31, 2019. Revenue recognized over time is not material to our overall Consolidated Financial Statements. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products or services. Sales, value add, and other taxes we collect concurrently with revenue-producing activities are excluded from revenue. As a practical expedient, we may exclude the assessment of whether goods or services are performance obligations, if they are immaterial in the context of the contract, and combine these with other performance obligations. While payment terms and conditions vary by contract type, we have determined that our contracts generally do not include a significant financing component. We have elected to apply the practical expedient to treat all shipping and handling costs as fulfillment costs as a significant portion of these costs are incurred prior to transfer of control to the customer. We have also elected to apply the practical expedient to expense sales commissions as they are incurred as the amortization period resulting from capitalizing the costs is one year or less. These costs are recorded within Selling and administrative expenses in our Consolidated Statements of Income. We offer assurance type warranties on our products as well as separately sold warranty contracts. Revenue related to warranty contracts that are sold separately is recognized over the life of the warranty term. Certain arrangements may include installation, installation supervision, training, and spare parts, which tend to be completed in a short period of time, at an insignificant cost, and utilizing skills not unique to us, and, therefore, are typically regarded as inconsequential or not material. We disclose disaggregated revenues by operating segment and geography in accordance with the revenue standard and on the same basis used internally by the chief operating decision maker for evaluating performance of operating segments and for allocating resources. Refer to Note 11 for details on our operating segments.
Earnings Per Share	Earnings per share ptions were excluded from the calculation of diluted earnings per share for the three months ended July 31, 2019.

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Jul. 31, 2020
Inventory Disclosure [Abstract]
Schedule of Inventories	At July 31, 2020 and October 31, 2019, inventories consisted of the following: July 31, 2020 October 31, 2019 Finished goods $ 196,611 $ 183,973 Raw materials and component parts 107,145 102,044 Work-in-process 54,123 42,904 357,879 328,921 Obsolescence and other reserves (41,570 ) (39,377 ) LIFO reserve (5,752 ) (6,145 ) $ 310,557 $ 283,399

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets (Tables)	9 Months Ended
	Jul. 31, 2020
Goodwill And Intangible Assets Disclosure [Abstract]
Summary of Changes in Carrying Amount of Goodwill	Changes in the carrying amount of goodwill for the nine months ended July 31, 2020 by operating segment are as follows: Industrial Precision Solutions Advanced Technology Solutions Total Balance at October 31, 2019 $ 411,461 $ 1,203,278 $ 1,614,739 Acquisitions — 76,047 76,047 Currency effect 6,088 5,040 11,128 Balance at July 31, 2020 $ 417,549 $ 1,284,365 $ 1,701,914
Summary of Intangible Assets Subject to Amortization	Information regarding our intangible assets subject to amortization is as follows: July 31, 2020 Carrying Accumulated Amortization Net Customer relationships $ 503,804 $ 203,589 $ 300,215 Patent/technology costs 163,550 81,590 81,960 Trade name 98,691 46,553 52,138 Non-compete agreements 12,472 10,972 1,500 Other 1,401 1,397 4 Total $ 779,918 $ 344,101 $ 435,817 October 31, 2019 Carrying Accumulated Amortization Net Book Value Customer relationships $ 480,007 $ 173,996 $ 306,011 Patent/technology costs 154,735 71,663 83,072 Trade name 96,655 41,303 55,352 Non-compete agreements 11,540 10,406 1,134 Other 1,400 1,394 6 Total $ 744,337 $ 298,762 $ 445,575

Pension and Other Postretirem_2

Pension and Other Postretirement Plans (Tables)	9 Months Ended
	Jul. 31, 2020
Pension Cost [Member]
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Components of Net Periodic Benefits Cost	The components of net periodic pension cost for the three and nine months ended July 31, 2020 and 2019 were: U.S. International Three Months Ended 2020 2019 2020 2019 Service cost $ 5,146 $ 3,740 $ 519 $ 484 Interest cost 3,970 4,736 256 416 Expected return on plan assets (6,165 ) (5,908 ) (313 ) (397 ) Amortization of prior service credit (21 ) (16 ) (72 ) (76 ) Amortization of net actuarial loss 3,510 1,938 739 424 Settlement loss 2,508 — — — Total benefit cost $ 8,948 $ 4,490 $ 1,129 $ 851 U.S. International Nine Months Ended 2020 2019 2020 2019 Service cost $ 15,439 $ 10,895 $ 1,550 $ 1,454 Interest cost 11,913 13,726 769 1,262 Expected return on plan assets (18,499 ) (17,506 ) (948 ) (1,204 ) Amortization of prior service credit (63 ) (46 ) (214 ) (228 ) Amortization of net actuarial loss 10,529 5,026 2,201 1,280 Settlement loss 2,508 — — — Total benefit cost $ 21,827 $ 12,095 $ 3,358 $ 2,564
Postretirement Benefit Costs [Member]
Defined Benefit Plans And Other Postretirement Benefit Plans Table Text Block [Line Items]
Components of Net Periodic Benefits Cost	The components of other postretirement benefit cost for the three and nine months ended July 31, 2020 and 2019 were: U.S. International Three Months Ended 2020 2019 2020 2019 Service cost $ 187 $ 70 $ 4 $ 3 Interest cost 657 698 3 3 Amortization of prior service credit (5 ) (6 ) — — Amortization of net actuarial (gain) loss 380 162 (9 ) (5 ) Total benefit cost $ 1,219 $ 924 $ (2 ) $ 1 U.S. International Nine Months Ended 2020 2019 2020 2019 Service cost $ 520 $ 401 $ 11 $ 13 Interest cost 1,830 2,195 10 15 Amortization of prior service credit (13 ) (20 ) — — Amortization of net actuarial (gain) loss 1,057 467 (27 ) (22 ) Total benefit cost $ 3,394 $ 3,043 $ (6 ) $ 6

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	9 Months Ended
	Jul. 31, 2020
Equity [Abstract]
Summary of Accumulated Other Comprehensive Loss	The components of accumulated other comprehensive loss, including adjustments for items that are reclassified from accumulated other comprehensive loss to net income, are shown below. Cumulative Pension and Accumulated translation postretirement benefit other comprehensive adjustments plan adjustments loss Balance at October 31, 2019 $ (53,332 ) $ (178,549 ) $ (231,881 ) Amortization of prior service costs and net actuarial losses, net of tax of $(3,026) — 9,748 9,748 Foreign currency translation adjustments 10,509 — 10,509 Balance at July 31, 2020 $ (42,823 ) $ (168,801 ) $ (211,624 )

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Jul. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Summarized Activity Related to Stock Options	The following table summarizes activity related to stock options for the nine months ended July 31, 2020: Number of Options Weighted- Average Exercise Share Aggregate Intrinsic Value Weighted Average Remaining Term Outstanding at October 31, 2019 1,787 $ 97.74 Granted 391 166.38 Exercised (587 ) 78.87 Forfeited or expired (39 ) 144.70 Outstanding at July 31, 2020 1,552 $ 121.00 $ 112,752 7.2 years Expected to vest 853 $ 141.34 $ 44,597 8.4 years Exercisable at July 31, 2020 689 $ 95.33 $ 67,769 5.7 years
Fair Value Assumptions of Stock Options	The fair value of each option grant was estimated at the date of grant using the Black-Scholes option-pricing model with the following assumptions: Nine months ended July 31, 2020 July 31, 2019 Expected volatility 24.5%-30.5% 24.1%-24.5% Expected dividend yield 0.87%-1.16% 1.04% Risk-free interest rate 0.44%-1.69% 2.84%-2.95% Expected life of the option (in years) 5.3-6.3 5.3-6.2
Summarized Activity Related to Restricted Stock	The following table summarizes activity related to restricted shares during the nine months ended July 31, 2020: Number of Shares Weighted-Average Grant Date Fair Value Restricted shares at October 31, 2019 66 $ 126.83 Granted 25 169.62 Forfeited (6 ) 131.06 Vested (26 ) 120.23 Restricted shares at July 31, 2020 59 $ 147.17
Summarized Activity Related to Restricted Stock Units	The following table summarizes activity related to restricted share units during the nine months ended July 31, 2020: Number of Units Weighted-Average Grant Date Fair Value Restricted share units at October 31, 2019 — $ — Granted 7 160.68 Restricted share units at July 31, 2020 7 $ 160.68
Summarized Activity Related to Director Deferred Compensation Shares	The following table summarizes activity related to director deferred compensation share equivalent units during the nine months ended July 31, 2020: Number of Shares Weighted-Average Grant Date Fair Value Outstanding at October 31, 2019 114 $ 55.52 Dividend equivalents 1 164.44 Outstanding at July 31, 2020 115 $ 56.27

Warranties (Tables)

Warranties (Tables)	9 Months Ended
	Jul. 31, 2020
Guarantees [Abstract]
Reconciliation of Product Warranty Liability	Following is a reconciliation of the product warranty liability for the nine months ended July 31, 2020 and 2019: July 31, 2020 July 31, 2019 Beginning balance at October 31 $ 11,006 $ 12,195 Accruals for warranties 8,219 7,628 Warranty payments (8,180 ) (7,837 ) Currency effect 221 (78 ) Ending balance $ 11,266 $ 11,908

Operating Segments (Tables)

Operating Segments (Tables)	9 Months Ended
	Jul. 31, 2020
Segment Reporting [Abstract]
Segments	The following table presents information about our segments: Industrial Precision Solutions Advanced Technology Solutions Corporate Total Three months ended July 31, 2020 Net external sales $ 288,965 $ 249,216 $ — $ 538,181 Operating profit (loss) 74,744 49,952 (12,641 ) 112,055 July 31, 2019 Net external sales $ 306,648 $ 253,098 $ — $ 559,746 Operating profit (loss) 88,811 53,562 (12,097 ) 130,276 Nine months ended July 31, 2020 Net external sales $ 835,038 $ 727,537 $ — $ 1,562,575 Operating profit (loss) 207,603 140,928 (36,354 ) 312,177 July 31, 2019 Net external sales $ 871,925 $ 736,850 $ — $ 1,608,775 Operating profit (loss) 229,702 150,882 (37,131 ) 343,453
Reconciliation of Segment Operating Income to Consolidated Income Before Income Taxes	A reconciliation of total segment operating income to total consolidated income before income taxes is as follows: Three Months Ended Nine Months Ended July 31, 2020 July 31, 2019 July 31, 2020 July 31, 2019 Total profit for reportable segments $ 112,055 $ 130,276 $ 312,177 $ 343,453 Interest expense (7,314 ) (11,500 ) (25,348 ) (36,238 ) Interest and investment income 434 511 1,301 1,153 Other-net (9,668 ) 210 (12,943 ) (4,546 ) Income before income taxes $ 95,507 $ 119,497 $ 275,187 $ 303,822
Sales and Long-lived Asset Information by Geographic Regions	We have significant sales in the following geographic regions: Three Months Ended Nine Months Ended July 31, 2020 July 31, 2019 July 31, 2020 July 31, 2019 United States $ 183,508 $ 190,460 $ 560,941 $ 551,510 Americas 38,265 47,040 106,021 123,159 Europe 132,107 143,449 394,554 425,650 Japan 31,226 30,488 90,353 89,566 Asia Pacific 153,075 148,309 410,706 418,890 Total net external sales $ 538,181 $ 559,746 $ 1,562,575 $ 1,608,775

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Jul. 31, 2020
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis	The following tables present the classification of our assets and liabilities measured at fair value on a recurring basis: July 31, 2020 Total Level 1 Level 2 Level 3 Assets: Foreign currency forward contracts (a) $ 22,241 $ — $ 22,241 $ — Total assets at fair value $ 22,241 $ — $ 22,241 $ — Liabilities: Deferred compensation plans (b) $ 12,030 $ — $ 12,030 $ — Foreign currency forward contracts (a) 6,484 — 6,484 — Total liabilities at fair value $ 18,514 $ — $ 18,514 $ — October 31, 2019 Total Level 1 Level 2 Level 3 Assets: Foreign currency forward contracts (a) $ 5,042 $ — $ 5,042 $ — Total assets at fair value $ 5,042 $ — $ 5,042 $ — Liabilities: Deferred compensation plans (b) $ 11,850 $ — $ 11,850 $ — Foreign currency forward contracts (a) 2,381 — 2,381 — Total liabilities at fair value $ 14,231 $ — $ 14,231 $ — (a) We enter into foreign currency forward contracts to reduce the risk of foreign currency exposures resulting from receivables, payables, intercompany receivables, intercompany payables and loans denominated in foreign currencies. Foreign exchange contracts are valued using market exchange rates. These foreign exchange contracts are not designated as hedges. (b) Executive officers and other highly compensated employees may defer up to 100 percent of their salary and annual cash incentive compensation and for executive officers, up to 90 percent of their long-term incentive compensation, into various non-qualified deferred compensation plans. Deferrals can be allocated to various market performance measurement funds. Changes in the value of compensation deferred under these plans are recognized each period based on the fair value of the underlying measurement funds.
Carrying Amounts and Fair Values of Financial Instruments, Other than Cash and Cash Equivalents, Receivables and Accounts Payable	The carrying values of cash and cash equivalents, receivables and accounts payable approximate fair value due to the short-term nature of these instruments. July 31, 2020 Carrying Amount Fair Value Long-term debt (including current portion), excluding unamortized debt issuance costs 1,264,680 1,330,739

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	9 Months Ended
	Jul. 31, 2020
Investments All Other Investments [Abstract]
Outstanding Currency, Forward Exchange Contracts	The following table summarizes, by currency, the foreign currency forward contracts outstanding at July 31, 2020 and 2019: Notional Amounts July 31, 2020 contract amounts: Sell Buy Euro $ 108,856 $ 207,198 British pound 18,861 60,397 Japanese yen 15,815 32,009 Australian dollar 174 7,682 Hong Kong dollar 56,279 74,714 Singapore dollar 1,357 15,982 Others 4,412 59,921 Total $ 205,754 $ 457,903 Notional Amounts July 31, 2019 contract amounts: Sell Buy Euro $ 219,910 $ 90,043 British pound 20,542 45,955 Japanese yen 32,560 48,670 Australian dollar 350 7,683 Hong Kong dollar 1,209 136,818 Singapore dollar 782 15,449 Others 3,460 63,388 Total $ 278,813 $ 408,006

Leases (Tables)

Leases (Tables)	9 Months Ended
	Jul. 31, 2020
Leases [Abstract]
Schedule of Additional Lease Information Under Finance and Operating Leases	Additional lease information is summarized below for the three and nine months ended July 31, 2020: Three months ended Nine months ended July 31, 2020 July 31, 2020 Finance Leases Operating Leases Finance Leases Operating Leases Amortization of right of use assets $ 1,779 $ — $ 5,293 $ — Interest 93 — 266 — Lease cost (1) 1,872 5,406 5,559 16,073 Short-term and variable lease cost (1) 200 617 1,023 1,917 Total lease cost $ 2,072 $ 6,023 $ 6,582 $ 18,000 (1) Lease costs are recorded in both Cost of sales and Selling and administrative expenses on the Consolidated Statements of Income.
Schedule of Supplemental Cash Flow Information Related to Leases	Supplemental cash flow information is summarized below for the nine months ended July 31, 2020: Finance Leases Operating Leases Cash outflows for leases $ 5,814 $ 15,935 Weighted average remaining lease term (years) 4.72 years 10.48 years Weighted average discount rate 2.51 % 1.69 %
Schedule of Reconciliation of Undiscounted Cash Flows for Operating and Finance Lease Liabilities	The following table reconciles the undiscounted cash flows for five years and thereafter to the operating and finance lease liabilities recognized on the statement of financial position as of July 31, 2020. The reconciliation excludes short-term leases that are not recognized on the Consolidated Balance Sheet. Year: Finance Leases Operating Leases 2020 $ 6,479 $ 20,709 2021 4,445 19,056 2022 2,735 16,106 2023 1,130 14,163 2024 669 12,160 Later years 3,210 68,085 Total minimum lease payments $ 18,668 $ 150,279 Amounts representing interest 1,462 14,034 Present value of minimum lease payments $ 17,206 $ 136,245

Long-Term Debt (Tables)

Long-Term Debt (Tables)	9 Months Ended
	Jul. 31, 2020
Debt Disclosure [Abstract]
Long-Term Debt	A summary of long-term debt is as follows: July 31, 2020 October 31, 2019 Senior notes, due 2020-2025 $ 109,900 $ 140,800 Senior notes, due 2020-2027 85,714 92,857 Senior notes, due 2023-2030 350,000 350,000 Term loan, due 2022-2024 405,000 505,000 Euro loan, due 2023 312,022 128,219 Private shelf facility, due 2020 5,556 30,556 Development loans, due 2020-2026 — 951 1,268,192 1,248,383 Less current maturities 43,598 168,738 Less unamortized debt issuance costs 3,512 4,241 Long-term maturities $ 1,221,082 $ 1,075,404

Significant Accounting Polici_3

Significant Accounting Policies - Additional Information (Detail) - shares	3 Months Ended		9 Months Ended
	Jul. 31, 2020	Jul. 31, 2019	Jul. 31, 2020	Jul. 31, 2019
Significant Accounting Policies [Line Items]
Ownership percentage in affiliates and joint ventures	50.00%		50.00%
Stock Options [Member]
Significant Accounting Policies [Line Items]
Options for common shares excluded from computation of diluted earning per share	210,000	0	127,000	235,000

Recently Issued Accounting St_2

Recently Issued Accounting Standards - Additional Information (Detail) - USD ($) $ in Thousands	Jul. 31, 2020	Nov. 01, 2019	Aug. 31, 2018
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Operating right-of-use assets	$ 132,062
Operating lease liabilities	136,245
ASU 2016-02 [Member]
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Operating right-of-use assets	132,062	$ 130,583
Operating lease liabilities	$ 136,245	$ 134,853
New Accounting Guidance Issued and Not Yet Adopted [Member]
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Defined benefit plan effect of percentage change in assumed health care cost trend rates			1.00%

Acquisitions - Additional Infor

Acquisitions - Additional Information (Detail) - USD ($) $ in Thousands	Jun. 01, 2020	Jul. 31, 2020	Jul. 31, 2019	Oct. 31, 2019
Business Acquisition [Line Items]
Acquisition of businesses, net of cash acquired		$ 125,260	$ 12,110
Goodwill		$ 1,701,914		$ 1,614,739
Fluortek [Member] | 2020 Acquisition [Member]
Business Acquisition [Line Items]
Acquired percent of the outstanding shares	100.00%
Acquisition of businesses, net of cash acquired	$ 125,260
Cash acquired from business acquisition	515
Goodwill	76,047
Identifiable intangible assets	29,370
Property, plant and equipment and working capital – net	19,843
Fluortek [Member] | Customer Relationships [Member] | 2020 Acquisition [Member]
Business Acquisition [Line Items]
Identifiable intangible assets	$ 19,700
Intangible assets amortization period	12 years
Fluortek [Member] | Technology-Based Intangible Assets [Member] | 2020 Acquisition [Member]
Business Acquisition [Line Items]
Identifiable intangible assets	$ 7,400
Intangible assets amortization period	10 years
Fluortek [Member] | Trade Names [Member] | 2020 Acquisition [Member]
Business Acquisition [Line Items]
Identifiable intangible assets	$ 1,500
Intangible assets amortization period	10 years
Fluortek [Member] | Non-compete Agreements [Member] | 2020 Acquisition [Member]
Business Acquisition [Line Items]
Identifiable intangible assets	$ 770
Intangible assets amortization period	5 years

Inventories - Schedule of Inven

Inventories - Schedule of Inventories (Detail) - USD ($) $ in Thousands	Jul. 31, 2020	Oct. 31, 2019
Inventory Disclosure [Abstract]
Finished goods	$ 196,611	$ 183,973
Raw materials and component parts	107,145	102,044
Work-in-process	54,123	42,904
Inventories - gross	357,879	328,921
Obsolescence and other reserves	(41,570)	(39,377)
LIFO reserve	(5,752)	(6,145)
Inventories - net	$ 310,557	$ 283,399

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets - Summary of Changes in Carrying Amount of Goodwill (Detail) $ in Thousands	9 Months Ended
	Jul. 31, 2020USD ($)
Goodwill [Line Items]
Beginning balance	$ 1,614,739
Acquisitions	76,047
Currency effect	11,128
Ending balance	1,701,914
Industrial Precision Solutions [Member]
Goodwill [Line Items]
Beginning balance	411,461
Currency effect	6,088
Ending balance	417,549
Advanced Technology Solutions [Member]
Goodwill [Line Items]
Beginning balance	1,203,278
Acquisitions	76,047
Currency effect	5,040
Ending balance	$ 1,284,365

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets - Summary of Intangible Assets Subject to Amortization (Detail) - USD ($) $ in Thousands	Jul. 31, 2020	Oct. 31, 2019
Finite Lived Intangible Assets [Line Items]
Carrying Amount	$ 779,918	$ 744,337
Accumulated Amortization	344,101	298,762
Net Book Value	435,817	445,575
Customer Relationships [Member]
Finite Lived Intangible Assets [Line Items]
Carrying Amount	503,804	480,007
Accumulated Amortization	203,589	173,996
Net Book Value	300,215	306,011
Patent/Technology Costs [Member]
Finite Lived Intangible Assets [Line Items]
Carrying Amount	163,550	154,735
Accumulated Amortization	81,590	71,663
Net Book Value	81,960	83,072
Trade Names [Member]
Finite Lived Intangible Assets [Line Items]
Carrying Amount	98,691	96,655
Accumulated Amortization	46,553	41,303
Net Book Value	52,138	55,352
Non-compete Agreements [Member]
Finite Lived Intangible Assets [Line Items]
Carrying Amount	12,472	11,540
Accumulated Amortization	10,972	10,406
Net Book Value	1,500	1,134
Other [Member]
Finite Lived Intangible Assets [Line Items]
Carrying Amount	1,401	1,400
Accumulated Amortization	1,397	1,394
Net Book Value	$ 4	$ 6

Goodwill and Other Intangible_5

Goodwill and Other Intangible Assets - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2020	Jul. 31, 2019	Jul. 31, 2020	Jul. 31, 2019
Goodwill And Intangible Assets Disclosure [Abstract]
Intangible assets, amortization expense	$ 16,577	$ 13,903	$ 47,410	$ 41,665

Pension and Other Postretirem_3

Pension and Other Postretirement Plans - Net Periodic Benefit Cost (Detail) - Pension Plans [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2020	Jul. 31, 2019	Jul. 31, 2020	Jul. 31, 2019
United States [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 5,146	$ 3,740	$ 15,439	$ 10,895
Interest cost	3,970	4,736	11,913	13,726
Expected return on plan assets	(6,165)	(5,908)	(18,499)	(17,506)
Amortization of prior service credit	(21)	(16)	(63)	(46)
Amortization of net actuarial loss	3,510	1,938	10,529	5,026
Settlement loss	2,508		2,508
Total benefit cost	8,948	4,490	21,827	12,095
International [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	519	484	1,550	1,454
Interest cost	256	416	769	1,262
Expected return on plan assets	(313)	(397)	(948)	(1,204)
Amortization of prior service credit	(72)	(76)	(214)	(228)
Amortization of net actuarial loss	739	424	2,201	1,280
Total benefit cost	$ 1,129	$ 851	$ 3,358	$ 2,564

Pension and Other Postretirem_4

Pension and Other Postretirement Plans - Additional Information (Detail) $ in Thousands	3 Months Ended
	Jul. 31, 2020USD ($)
Lump Sum Distribution from Supplemental Executive Retirement Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Settlement loss	$ 2,508

Pension and Other Postretirem_5

Pension and Other Postretirement Plans - Other Postretirement Benefit Cost (Detail) - Postretirement Benefit Costs [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2020	Jul. 31, 2019	Jul. 31, 2020	Jul. 31, 2019
United States [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 187	$ 70	$ 520	$ 401
Interest cost	657	698	1,830	2,195
Amortization of prior service credit	(5)	(6)	(13)	(20)
Amortization of net actuarial (gain) loss	380	162	1,057	467
Total benefit cost	1,219	924	3,394	3,043
International [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	4	3	11	13
Interest cost	3	3	10	15
Amortization of net actuarial (gain) loss	(9)	(5)	(27)	(22)
Total benefit cost	$ (2)	$ 1	$ (6)	$ 6

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2020	Jul. 31, 2019	Jul. 31, 2020	Jul. 31, 2019
Income Tax Disclosure [Abstract]
Effective tax rates	8.90%	21.40%	16.00%	22.80%
Income tax provision included discrete tax benefit due to share-based payment transactions	$ 11,373	$ 210	$ 14,048	$ 3,227
Provisional discrete tax (benefit) expense				4,866
Total unrecognized tax benefits	443	$ 858	$ 443	$ 858
Increase in unrecognized tax benefits	$ 5,664

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss - Summary of Accumulated Other Comprehensive Loss (Detail) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Jul. 31, 2020	Apr. 30, 2020	Jan. 31, 2020	Jul. 31, 2019	Apr. 30, 2019	Jan. 31, 2019	Jul. 31, 2020	Jul. 31, 2019
Accumulated Other Comprehensive Income Loss [Line Items]
Accumulated other comprehensive income (loss), Beginning balance			$ (231,881)				$ (231,881)
Amortization of prior service costs and net actuarial losses, net of tax of $(3,026)	$ 2,621			$ 2,378			9,748	$ 5,328
Foreign currency translation adjustments	28,943	$ (21,227)	2,793	$ (7,172)	$ (9,064)	$ 16,463	10,509	$ 227
Accumulated other comprehensive loss, Ending balance	(211,624)						(211,624)
Cumulative Translation Adjustments [Member]
Accumulated Other Comprehensive Income Loss [Line Items]
Accumulated other comprehensive income (loss), Beginning balance			(53,332)				(53,332)
Foreign currency translation adjustments							10,509
Accumulated other comprehensive loss, Ending balance	(42,823)						(42,823)
Pension And Postretirement Benefit Plan Adjustments [Member]
Accumulated Other Comprehensive Income Loss [Line Items]
Accumulated other comprehensive income (loss), Beginning balance			$ (178,549)				(178,549)
Amortization of prior service costs and net actuarial losses, net of tax of $(3,026)							9,748
Accumulated other comprehensive loss, Ending balance	$ (168,801)						$ (168,801)

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Loss - Summary of Accumulated Other Comprehensive Loss (Parenthetical) (Detail) $ in Thousands	9 Months Ended
	Jul. 31, 2020USD ($)
Accumulated Other Comprehensive Income Loss Net Of Tax [Abstract]
Amortization of prior service costs and net actuarial losses, tax	$ 3,026

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2020	Jul. 31, 2019	Jul. 31, 2020	Jul. 31, 2019	Jul. 31, 2018
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Maximum number of common shares available for grant	4,525		4,525
Executive officers and other highly compensated employees salary and annual cash incentive compensation deferrals percentage, maximum			100.00%
Executive officers share-based long-term incentive compensation deferrals percentage, maximum			90.00%
Stock Options [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Maximum rate of stock option, description			not exceeding 25 percent per year
Option expiring period			10 years
Compensation expense recognized	$ 2,385	$ 2,525	$ 7,648	$ 7,583
Options exercisable beginning period			1 year
Normal retirement age			65 years
Period for options considered to be forfeited for retirees			12 months
Termination period on death or disability of option holder			12 months
Options grants in period vesting period			Dec. 28, 2017
Unrecognized compensation cost related to unvested stock option	13,963		$ 13,963
Weighted average period expected to be amortized, non vested shares			1 year 8 months 12 days
Weighted-average expected volatility used			25.40%	24.30%
Weighted average grant date fair value of stock options granted			$ 38.57	$ 31.74
Total intrinsic value of options exercised	39,811	2,449	$ 58,758	$ 21,770
Cash received from the exercise of stock options			$ 46,304	17,275
Stock Options [Member] | Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Maximum rate of stock option			25.00%
Restricted Shares and Restricted Share Units [Member] | Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Grant restricted shares transferred period			3 years
Restricted Shares and Restricted Share Units [Member] | Minimum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Grant restricted shares transferred period			1 year
Restricted Stock [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Normal retirement age			65 years
Weighted average period expected to be amortized, non vested shares			2 years
Period for restricted shares and share units considered to be forfeited for retirees			12 months
Restricted shares termination period for disability or death			12 months
Restriction period for restricted shares granted			Dec. 28, 2017
Unrecognized compensation cost related to nonvested restricted stock	5,053		$ 5,053
Expense related to nonvested common shares	734	898	2,995	2,762
Common share dividends amount included in compensation cost	21	22	$ 64	58
Restricted Stock Unit [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Weighted average period expected to be amortized, non vested shares			3 months 18 days
Period for pro-rata vesting of shares or units for non-employee directors			1 year
Unrecognized compensation cost related to nonvested restricted stock	295		$ 295
Expense related to nonvested common shares	299	263	883	789
Performance Share Incentive Awards [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Compensation expense		15		$ 1,611
Compensation credited to expense	552		2,834
Cumulative amount recorded in shareholders' equity related to Long-Term Incentive Plan	1,455		$ 1,455
Periods of performance considered for calculating compensation expense			3 years
Performance Share Incentive Awards [Member] | November 25, 2019 [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Weighted average grant date fair value			$ 160.02
Performance Share Incentive Awards [Member] | March 30, 2020 [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Weighted average grant date fair value			133.01
Performance Share Incentive Awards [Member] | November 26, 2018 [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Weighted average grant date fair value				$ 120.12
Performance Share Incentive Awards [Member] | July 6. 2020 [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Weighted average grant date fair value			$ 184.04
Performance Share Incentive Awards [Member] | August 1, 2019 [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Weighted average grant date fair value				$ 138.53	$ 138.53
Performance Share Incentive Awards [Member] | November 20, 2017 [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Weighted average grant date fair value					$ 123.45
Deferred Compensation [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common share dividends amount included in compensation cost	83	74	$ 247	$ 219
Executive officers and other highly compensated employees salary and annual cash incentive compensation deferrals percentage, maximum			100.00%
Executive officers share-based long-term incentive compensation deferrals percentage, maximum			90.00%
Deferred Compensation [Member] | Directors [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expense related to director deferred compensation	$ 44	$ 38	$ 130	$ 113

Stock-Based Compensation - Summ

Stock-Based Compensation - Summarized Activity Related to Stock Options (Detail) - Stock Options [Member] $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended
	Jul. 31, 2020USD ($)$ / sharesshares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of Options, Outstanding, Beginning balance | shares	1,787
Number of Options, Granted | shares	391
Number of Options, Exercised | shares	(587)
Number of Options, Forfeited or expired | shares	(39)
Number of Options, Outstanding, Ending balance | shares	1,552
Number of Options, Expected to vest | shares	853
Number of Options, Exercisable | shares	689
Weighted-Average Exercise Price Per Share, Outstanding, Beginning balance | $ / shares	$ 97.74
Weighted-Average Exercise Price Per Share, Granted | $ / shares	166.38
Weighted-Average Exercise Price Per Share, Exercised | $ / shares	78.87
Weighted-Average Exercise Price Per Share, Forfeited or expired | $ / shares	144.70
Weighted-Average Exercise Price Per Share, Outstanding, Ending balance | $ / shares	121
Weighted-Average Exercise Price Per Share, Expected to vest | $ / shares	141.34
Weighted-Average Exercise Price Per Share, Exercisable | $ / shares	$ 95.33
Aggregate Intrinsic Value, Outstanding | $	$ 112,752
Aggregate Intrinsic Value, Expected to vest | $	44,597
Aggregate Intrinsic Value, Exercisable | $	$ 67,769
Weighted Average Remaining Term, Outstanding	7 years 2 months 12 days
Weighted Average Remaining Term, Expected to vest	8 years 4 months 24 days
Weighted Average Remaining Term, Exercisable	5 years 8 months 12 days

Stock-Based Compensation - Fair

Stock-Based Compensation - Fair Value Assumptions of Stock Options (Detail) - Stock Options [Member]	9 Months Ended
	Jul. 31, 2020	Jul. 31, 2019
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected volatility, Minimum	24.50%	24.10%
Expected volatility, Maximum	30.50%	24.50%
Expected dividend yield		1.04%
Risk-free interest rate, Minimum	0.44%	2.84%
Risk-free interest rate, Maximum	1.69%	2.95%
Minimum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected dividend yield	0.87%
Expected life of the option (in years)	5 years 3 months 18 days	5 years 3 months 18 days
Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected dividend yield	1.16%
Expected life of the option (in years)	6 years 3 months 18 days	6 years 2 months 12 days

Stock-Based Compensation - Su_2

Stock-Based Compensation - Summarized Activity Related to Restricted Stock (Detail) - Restricted Stock [Member] shares in Thousands	9 Months Ended
	Jul. 31, 2020$ / sharesshares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of Restricted Shares/Units, Beginning balance | shares	66
Number of Restricted Shares, Granted | shares	25
Number of Restricted Shares, Forfeited | shares	(6)
Number of Restricted Shares, Vested | shares	(26)
Number of Restricted Shares/Units, Ending balance | shares	59
Weighted-Average Grant Date Fair Value, Restricted Shares, Beginning balance | $ / shares	$ 126.83
Weighted-Average Grant Date Fair Value, Granted | $ / shares	169.62
Weighted-Average Grant Date Fair Value, Forfeited | $ / shares	131.06
Weighted-Average Grant Date Fair Value, Vested | $ / shares	120.23
Weighted-Average Grant Date Fair Value, Restricted Shares, Ending balance | $ / shares	$ 147.17

Stock-Based Compensation - Su_3

Stock-Based Compensation - Summarized Activity Related to Restricted Stock Units (Detail) - Restricted Stock Unit [Member] shares in Thousands	9 Months Ended
	Jul. 31, 2020$ / sharesshares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of Restricted Share Units, Granted | shares	7
Number of Restricted Shares/Units, Ending balance | shares	7
Weighted-Average Grant Date Fair Value, Granted | $ / shares	$ 160.68
Weighted-Average Grant Date Fair Value, Restricted Shares, Ending balance | $ / shares	$ 160.68

Stock-Based Compensation - Su_4

Stock-Based Compensation - Summarized Activity Related to Director Deferred Compensation Shares (Detail) - Directors [Member] - Deferred Compensation Share Equivalent Units [Member] shares in Thousands	9 Months Ended
	Jul. 31, 2020$ / sharesshares
Deferred Compensation Arrangement With Individual Share Based Payments [Line Items]
Number of Shares, Outstanding, Beginning balance | shares	114
Number of Shares, Dividend equivalents | shares	1
Number of Shares, Outstanding, Ending balance | shares	115
Weighted-Average Grant Date Fair Value, Beginning balance | $ / shares	$ 55.52
Weighted-Average Grant Date Fair Value, Dividend equivalents | $ / shares	164.44
Weighted-Average Grant Date Fair Value, Ending balance | $ / shares	$ 56.27

Warranties - Additional Informa

Warranties - Additional Information (Detail)	9 Months Ended
	Jul. 31, 2020
Guarantees [Abstract]
Product warranty period	1 year

Warranties - Reconciliation of

Warranties - Reconciliation of Product Warranty Liability (Detail) - USD ($) $ in Thousands	9 Months Ended
	Jul. 31, 2020	Jul. 31, 2019
Guarantees [Abstract]
Beginning balance at October 31	$ 11,006	$ 12,195
Accruals for warranties	8,219	7,628
Warranty payments	(8,180)	(7,837)
Currency effect	221	(78)
Ending balance	$ 11,266	$ 11,908

Operating Segments - Additional

Operating Segments - Additional Information (Detail)	9 Months Ended
	Jul. 31, 2020Segment
Segment Reporting [Abstract]
Number of operating segments	2

Operating Segments - Segments (

Operating Segments - Segments (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2020	Jul. 31, 2019	Jul. 31, 2020	Jul. 31, 2019
Segment Reporting Information [Line Items]
Net external sales	$ 538,181	$ 559,746	$ 1,562,575	$ 1,608,775
Operating profit (loss)	112,055	130,276	312,177	343,453
Operating Segments [Member]
Segment Reporting Information [Line Items]
Net external sales	538,181	559,746	1,562,575	1,608,775
Operating profit (loss)	112,055	130,276	312,177	343,453
Operating Segments [Member] | Industrial Precision Solutions [Member]
Segment Reporting Information [Line Items]
Net external sales	288,965	306,648	835,038	871,925
Operating profit (loss)	74,744	88,811	207,603	229,702
Operating Segments [Member] | Advanced Technology Solutions [Member]
Segment Reporting Information [Line Items]
Net external sales	249,216	253,098	727,537	736,850
Operating profit (loss)	49,952	53,562	140,928	150,882
Corporate [Member]
Segment Reporting Information [Line Items]
Operating profit (loss)	$ (12,641)	$ (12,097)	$ (36,354)	$ (37,131)

Operating Segments - Reconcilia

Operating Segments - Reconciliation of Segment Operating Income to Consolidated Income Before Income Taxes (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2020	Jul. 31, 2019	Jul. 31, 2020	Jul. 31, 2019
Segment Reporting [Abstract]
Total profit for reportable segments	$ 112,055	$ 130,276	$ 312,177	$ 343,453
Interest expense	(7,314)	(11,500)	(25,348)	(36,238)
Interest and investment income	434	511	1,301	1,153
Other - net	(9,668)	210	(12,943)	(4,546)
Income before income taxes	$ 95,507	$ 119,497	$ 275,187	$ 303,822

Operating Segments - Sales Info

Operating Segments - Sales Information by Geographic Regions (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2020	Jul. 31, 2019	Jul. 31, 2020	Jul. 31, 2019
Net external sales
Net external sales	$ 538,181	$ 559,746	$ 1,562,575	$ 1,608,775
United States [Member]
Net external sales
Net external sales	183,508	190,460	560,941	551,510
Americas [Member]
Net external sales
Net external sales	38,265	47,040	106,021	123,159
Europe [Member]
Net external sales
Net external sales	132,107	143,449	394,554	425,650
Japan [Member]
Net external sales
Net external sales	31,226	30,488	90,353	89,566
Asia Pacific [Member]
Net external sales
Net external sales	$ 153,075	$ 148,309	$ 410,706	$ 418,890

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - Recurring [Member] - USD ($) $ in Thousands		Jul. 31, 2020	Oct. 31, 2019
Assets:
Foreign currency forward contracts	[1]	$ 22,241	$ 5,042
Total assets at fair value		22,241	5,042
Liabilities:
Deferred compensation plans	[2]	12,030	11,850
Foreign currency forward contracts	[1]	6,484	2,381
Total liabilities at fair value		18,514	14,231
Level 2 [Member]
Assets:
Foreign currency forward contracts	[1]	22,241	5,042
Total assets at fair value		22,241	5,042
Liabilities:
Deferred compensation plans	[2]	12,030	11,850
Foreign currency forward contracts	[1]	6,484	2,381
Total liabilities at fair value		$ 18,514	$ 14,231
[1]	We enter into foreign currency forward contracts to reduce the risk of foreign currency exposures resulting from receivables, payables, intercompany receivables, intercompany payables and loans denominated in foreign currencies. Foreign exchange contracts are valued using market exchange rates. These foreign exchange contracts are not designated as hedges.
[2]	Executive officers and other highly compensated employees may defer up to 100 percent of their salary and annual cash incentive compensation and for executive officers, up to 90 percent of their long-term incentive compensation, into various non-qualified deferred compensation plans. Deferrals can be allocated to various market performance measurement funds. Changes in the value of compensation deferred under these plans are recognized each period based on the fair value of the underlying measurement funds.

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Parenthetical) (Detail)	9 Months Ended
	Jul. 31, 2020
Fair Value Disclosures [Abstract]
Executive officers and other highly compensated employees salary and annual cash incentive compensation deferrals percentage, maximum	100.00%
Executive officers share-based long-term incentive compensation deferrals percentage, maximum	90.00%

Fair Value Measurements - Carry

Fair Value Measurements - Carrying Amounts and Fair Values of Financial Instruments, Other than Cash and Cash Equivalents, Receivables and Accounts Payable (Detail) $ in Thousands	Jul. 31, 2020USD ($)
Schedule Of Carrying Amounts And Fair Values Of Financial Instruments [Abstract]
Long-term debt (including current portion), excluding unamortized debt issuance costs, Carrying Amount	$ 1,264,680
Long-term debt (including current portion), excluding unamortized debt issuance costs, Fair Value	$ 1,330,739

Derivative Financial Instrume_3

Derivative Financial Instruments - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 31, 2020	Jul. 31, 2019	Jul. 31, 2020	Jul. 31, 2019
Derivative Instruments And Hedging Activities Disclosure [Abstract]
Maturity of foreign currency forward contracts			90 days
Gains (losses) on foreign currency forward contracts	$ 17,255	$ 975	$ 13,096	$ 769
Gains (losses) in fair value of balance sheet positions denominated in foreign currencies	$ (20,809)	$ 407	$ (13,658)	$ 267

Derivative Financial Instrume_4

Derivative Financial Instruments - Outstanding Currency, Forward Exchange Contracts (Detail) - Foreign Currency Forward Contracts [Member] - USD ($) $ in Thousands	Jul. 31, 2020	Jul. 31, 2019
Sell [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	$ 205,754	$ 278,813
Buy [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	457,903	408,006
Euro [Member] | Sell [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	108,856	219,910
Euro [Member] | Buy [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	207,198	90,043
British Pound [Member] | Sell [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	18,861	20,542
British Pound [Member] | Buy [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	60,397	45,955
Japanese Yen [Member] | Sell [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	15,815	32,560
Japanese Yen [Member] | Buy [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	32,009	48,670
Australian Dollar [Member] | Sell [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	174	350
Australian Dollar [Member] | Buy [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	7,682	7,683
Hong Kong Dollar [Member] | Sell [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	56,279	1,209
Hong Kong Dollar [Member] | Buy [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	74,714	136,818
Singapore Dollar [Member] | Sell [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	1,357	782
Singapore Dollar [Member] | Buy [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	15,982	15,449
Others [Member] | Sell [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	4,412	3,460
Others [Member] | Buy [Member]
Derivative [Line Items]
Notional Amounts of foreign currency derivative contracts	$ 59,921	$ 63,388

Leases - Schedule of Additional

Leases - Schedule of Additional Lease Information Under Finance and Operating Leases (Detail) - USD ($) $ in Thousands		3 Months Ended	9 Months Ended
		Jul. 31, 2020	Jul. 31, 2020
Leases [Abstract]
Amortization of right of use assets		$ 1,779	$ 5,293
Interest		93	266
Lease Cost	[1]	1,872	5,559
Short-term and variable lease cost	[1]	200	1,023
Total lease cost		2,072	6,582
Lease Cost	[1]	5,406	16,073
Short-term and variable lease cost	[1]	617	1,917
Total lease cost		$ 6,023	$ 18,000
[1]	Lease costs are recorded in both Cost of sales and Selling and administrative expenses on the Consolidated Statements of Income

Leases - Schedule of Supplement

Leases - Schedule of Supplemental Cash Flow Information Related to Leases (Detail) - USD ($) $ in Thousands	9 Months Ended
	Jul. 31, 2020	Jul. 31, 2019
Finance Leases
Cash outflows for leases	$ 5,814	$ 4,442
Weighted average remaining lease term (years)	4 years 8 months 19 days
Weighted average discount rate	2.51%
Operating Leases
Cash outflows for leases	$ 15,935
Weighted average remaining lease term (years)	10 years 5 months 23 days
Weighted average discount rate	1.69%

Leases - Schedule of Reconcilia

Leases - Schedule of Reconciliation of Undiscounted Cash Flows for Operating and Finance Lease Liabilities (Detail) $ in Thousands	Jul. 31, 2020USD ($)
Finance Lease [Abstract]
2020	$ 6,479
2021	4,445
2022	2,735
2023	1,130
2024	669
Later years	3,210
Total minimum lease payments	18,668
Amounts representing interest	1,462
Present value of minimum lease payments	17,206
Operating Lease [Abstract]
2020	20,709
2021	19,056
2022	16,106
2023	14,163
2024	12,160
Later years	68,085
Total minimum lease payments	150,279
Amounts representing interest	14,034
Present value of minimum lease payments	$ 136,245

Long-Term Debt - Long-Term Debt

Long-Term Debt - Long-Term Debt (Detail) - USD ($) $ in Thousands	Jul. 31, 2020	Oct. 31, 2019
Debt Instrument [Line Items]
Private shelf facility, due 2020	$ 5,556	$ 30,556
Development loans, due 2020-2026		951
Long-term Debt	1,268,192	1,248,383
Less current maturities	43,598	168,738
Less unamortized debt issuance costs	3,512	4,241
Long-term maturities	1,221,082	1,075,404
Senior Notes, Due 2020-2025 [Member]
Debt Instrument [Line Items]
Senior notes	109,900	140,800
Senior Notes, Due 2020-2027 [Member]
Debt Instrument [Line Items]
Senior notes	85,714	92,857
Senior Notes, Due 2023-2030 [Member]
Debt Instrument [Line Items]
Senior notes	350,000	350,000
Term Loan, Due 2022-2024 [Member]
Debt Instrument [Line Items]
Term loan	405,000	505,000
Euro Loan, Due 2023 [Member]
Debt Instrument [Line Items]
Euro loan	$ 312,022	$ 128,219

Long-term Debt - Additional Inf

Long-term Debt - Additional Information (Detail) € in Thousands	Oct. 31, 2011USD ($)	Mar. 31, 2020EUR (€)	Apr. 30, 2019USD ($)	Jun. 30, 2018USD ($)	Jul. 31, 2015USD ($)	Jul. 31, 2020USD ($)	Oct. 31, 2016USD ($)	Oct. 31, 2015USD ($)	Oct. 31, 2012USD ($)	Jul. 31, 2020EUR (€)	Oct. 31, 2019USD ($)
Debt Instrument [Line Items]
Outstanding balance						$ 5,556,000					$ 30,556,000
Revolving Credit Agreement [Member]
Debt Instrument [Line Items]
Term loan expiration			2024-04
Debt instrument, covenant compliance description						We were in compliance with all covenants at July 31, 2020, and the amount we could borrow under the facility would not have been limited by any debt covenants.
Revolving credit facility			$ 850,000,000
Credit facility, term			5 years
Outstanding balance						$ 0					0
Revolving Credit Agreement [Member] | Swing Line Loans [Member]
Debt Instrument [Line Items]
Revolving credit facility			$ 75,000,000
Syndicated Revolving Credit Agreement [Member]
Debt Instrument [Line Items]
Revolving credit facility expiration			2020-02
Three-year Note Purchase and Private Shelf Agreement [Member]
Debt Instrument [Line Items]
Term loan expiration	2020-09
Debt instrument, covenant compliance description						We were in compliance with all covenants at July 31, 2020.
Debt instrument, face amount	$ 150,000,000
Debt instrument, fixed interest rates	2.21%
Period of agreement						3 years
Maximum credit facility							$ 200,000,000	$ 180,000,000
Outstanding balance						$ 5,556,000					30,556,000
Tranche One Euro Loan, Due in March 2023 [Member] | Bank of America [Member]
Debt Instrument [Line Items]
Term loan | €		€ 115,000
Term loan expiration		2023-03
Tranche Two Euro Loan, Due in March 2023 [Member] | Bank of America [Member]
Debt Instrument [Line Items]
Term loan | €		€ 150,000
Term loan expiration		2023-03
Euro Loan, Due 2023 [Member]
Debt Instrument [Line Items]
Euro loan						$ 312,022,000					128,219,000
Euro Loan, Due 2023 [Member] | Bank of America [Member]
Debt Instrument [Line Items]
Weighted average interest rate for borrowings						0.71%				0.71%
Euro loan						$ 312,022,000				€ 265,000
Debt instrument, covenant compliance description						We were in compliance with all covenants at July 31, 2020.
Term Loan Facility [Member] | Group of Banks [Member]
Debt Instrument [Line Items]
Term loan			$ 605,000,000			$ 405,000,000
Weighted average interest rate for borrowings						0.82%				0.82%
Debt instrument, covenant compliance description						We were in compliance with all covenants at July 31, 2020.
Term Loan Due in September 2022 [Member] | Group of Banks [Member]
Debt Instrument [Line Items]
Term loan						$ 200,000,000
Term Loan Due in March 2024 [Member] | Group of Banks [Member]
Debt Instrument [Line Items]
Term loan						$ 205,000,000
Senior Notes, Due 2023-2030 [Member]
Debt Instrument [Line Items]
Debt instrument, covenant compliance description						We were in compliance with all covenants at July 31, 2020.
Debt instrument, face amount				$ 350,000,000
Outstanding balance						$ 350,000,000					350,000,000
Senior Notes, Due 2023-2030 [Member] | Minimum [Member]
Debt Instrument [Line Items]
Term loan expiration				2023-06
Debt instrument, fixed interest rates				3.71%
Senior Notes, Due 2023-2030 [Member] | Maximum [Member]
Debt Instrument [Line Items]
Term loan expiration				2030-06
Debt instrument, fixed interest rates				4.17%
Senior Notes, Due 2020-2027 [Member]
Debt Instrument [Line Items]
Outstanding balance						$ 85,714,000					92,857,000
Senior Notes, Due 2020-2027 [Member] | Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Debt instrument, covenant compliance description						We were in compliance with all covenants at July 31, 2020.
Debt instrument, face amount					$ 100,000,000
Outstanding balance						$ 85,714,000					92,857,000
Senior Notes, Due 2020-2027 [Member] | Senior Unsecured Notes [Member] | Minimum [Member]
Debt Instrument [Line Items]
Term loan expiration					2021-07
Debt instrument, fixed interest rates					2.89%
Senior Notes, Due 2020-2027 [Member] | Senior Unsecured Notes [Member] | Maximum [Member]
Debt Instrument [Line Items]
Term loan expiration					2027-07
Debt instrument, fixed interest rates					3.19%
Senior Notes, Due 2020-2025 [Member]
Debt Instrument [Line Items]
Outstanding balance						$ 109,900,000					140,800,000
Senior Notes, Due 2020-2025 [Member] | Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Debt instrument, covenant compliance description						We were in compliance with all covenants at July 31, 2020.
Debt instrument, face amount									$ 200,000,000
Outstanding balance						$ 109,900,000					$ 140,800,000
Senior Notes, Due 2020-2025 [Member] | Senior Unsecured Notes [Member] | Minimum [Member]
Debt Instrument [Line Items]
Term loan expiration									2021-07
Debt instrument, fixed interest rates									2.62%
Senior Notes, Due 2020-2025 [Member] | Senior Unsecured Notes [Member] | Maximum [Member]
Debt Instrument [Line Items]
Term loan expiration									2025-07
Debt instrument, fixed interest rates									3.13%

Contingencies - Additional Info

Contingencies - Additional Information (Details) - USD ($) $ in Thousands	Jul. 31, 2020	Oct. 31, 2019
Commitments And Contingencies Disclosure [Abstract]
Accrual for environmental liability	$ 360	$ 401